Guest guest Posted May 30, 2008 Report Share Posted May 30, 2008 In all seriousness I think we need a study concerning the health effects, the loss of life inflicted by the stupidity of these " so- called " experts. The stats I'm sure would be astronomical. I guess some have a lower price (ethically that is)than others on selling their soul to the highest bidder. > > > And we wonder WHY people are not able to receive medical care for these > serious illnesses. > _http://www.johnshopkinshealthalerts.com/reports/lung_disorders/2012- 1.html_ > (http://www.johnshopkinshealthalerts.com/reports/lung_disorders/2012- 1.html) > Lung Disorders Special Report > > 9 Common Mold Myths > > > > > > Media reports have linked indoor mold exposure to everything from asthma to > headaches. But what’s the real scientific evidence that exposure to mold in > your home actually can cause physical symptoms? A recent review of scientific > literature about mold-related diseases found that, while mold can cause > certain health problems, many common claims just don’t hold up under scrutiny. > Five allergists, including A. Wood, M.D., of the s Hopkins > University School of Medicine, set out to define what can and can’t be proved about > mold exposure. Here’s what they found in their review: > Toxic mold. Popular reports about the health effects of mold are likely to > include the term “toxic mold.†But that term can be misleading, the experts > say. They point out that only certain mold spores produce toxins, and only > under certain circumstances. Just because a particular mold can produce toxins > doesn’t mean it will. Even if the mold is producing toxins, a person must > breathe in a sufficient dose to be affected. It is highly unlikely that you > could inhale enough mold in your home or office to receive a toxic dose. > Mold and Asthma. While allergic responses to inhaling mold are a recognized > factor in lower airway disease such as asthma, studies show that outdoor mold > is more likely to cause problems for asthmatics than mold found indoors. A > better assessment of the effects of indoor mold on people with asthma would > require studies that follow people over a long period and take into account > factors that could affect the results, such as humidity and other airborne > allergens and irritants. > Mold and Allergies. The link between mold and allergies is even weaker, the > experts say. Current research doesn’t provide a persuasive case that exposure > to mold in the outdoor air plays a role in allergies, and studies linking > indoor molds to upper airway allergy are even less compelling. > Mold and Skin Rashes. Exposure to molds doesn’t contribute to atopic > dermatitis, or rashes. > Mold and Sinusitis. There’s no clear-cut evidence that sensitivity to mold > causes chronic sinusitis, nor are there conclusive data to show that > mold-killing antifungal drugs such as amphotericin, applied to the nasal passages, are > an effective treatment for sinusitis. > Mold and Infection. Superficial fungal infections, such as toenail fungus or > jock itch, generally result from fungi that develop inside the warm, moist > environments found in shoes or tight garments. Thrush can develop inside the > mouths of people with weakened immune systems, such as those who have AIDS or > cancer. These infections generally are not the result of exposure to mold in > the home or workplace. > Mold and Irritation. Mold found indoors, even inside damp buildings, is not > likely to cause irritation of the eyes or throat -- and if it does, the > effects are short-lived. Symptoms or signs persisting weeks after exposure and > those accompanied by complaints related to the nervous system, brain, or whole > body (such as those attributed to chronic fatigue) can’t be pinned on the > irritant effects of mold exposure. > Mold and Immune System Damage. There is no credible evidence to suggest that > environmental exposure to mold damages the immune system. The experts warn > against immune-based tests given to look for intolerance to mold and other > substances in the environment†" so-called multiple chemical sensitivity. The > authors specifically advise against using blood tests that look for a wide range > of non-specific changes in the immune system. They also discourage using > tests of autoantibodies, which are abnormal antibodies that the body sometimes > produces in reaction against its own tissues. These tests are expensive and do > not provide useful information that will help to diagnose or manage diseases > related to mold, they say. > Mold and Hypersensitivity Pneumonitis. This uncommon inflammation of the > lungs, an example of which is Farmer’s Lung, is caused by exposure to an > allergen, usually organic dust that may come from animal dander, molds, or plants. A > person generally develops this condition only after high-dose or prolonged > exposure, or both, to mold or other allergens. > Much of the hoopla over mold exposure came in the wake of Hurricane Katrina, > the experts note in their report, which appeared in the Journal of Allergy > and Clinical Immunology. The flood-ravaged areas of the Gulf Coast, sadly, > have provided a natural laboratory, which enables medical researchers to address > lingering questions about the health effects of mold. > > > Posted in _Lung Disorders_ > (http://www.johnshopkinshealthalerts.com/reports/lung_disorders/) on May 22, 2008 > > > > > > **************Get trade secrets for amazing burgers. Watch " Cooking with > Tyler Florence " on AOL Food. > (http://food.aol.com/tyler-florence?video=4 & ? NCID=aolfod00030000000002) > > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted May 30, 2008 Report Share Posted May 30, 2008 ALL: I attempted to obtain entrance to at the website indicated at the end of this absolutely ignorant article, but found nothing to indicate that I could. So, frustrated enough, I will attempt to counter it here. First, what this propaganda and failed " research " does not state is far more important than what it does state. I do not know if many of you were able to catch a short article I authored a while ago regarding " allergens " as opposed to " pathogens, " but it is worth reprinting: Keep in mind that perhaps these looney so-called doctors of today must have been too busy with the " party life " and learning how to cheat on medical school exams than to buckle down on the sciences to understand the specifics of the microorganisms crawling on and beneath their feet! Had they done this, the popular idea that molds and bacteria are " allergens " would have been mute in medicine. Hence, my previous article: Let’s Talk Mold Exposures and Politics By R. Haney (Author: “Toxic Mold! Toxic Enemy!”) The Sacramento Bee recently printed a comment by Sandy McNeel, the California Department of Public Health that states, “Science hasn’t established a direct link between mold and specific illnesses.” This top-level so-called “scientist” clearly is behind the times by at least a decade and has no excuse for her deliberate lack of knowledge on the subject. Medical Mycology science, as well as other more complex fields of research dedicated to the bio and molecular sciences have unequivocally demonstrated both genetic mutations and cellular toxicity that are emphatically connected to human cancers, neurological disorders, and other serious debilitating diseases. Before proving this particular scientist’s educational defects, it is important to realize that she is not alone. There has been a concerted effort in both private industry and government to literally quash the “Mold Is Gold” era of public health. What the public has not yet caught onto is that unlike diseases caused by bacteria and viruses, diseases caused by microfungi (i.e., molds and yeasts) are not reportable by doctors, hospitals, and medical centers to monitoring agencies of the state and federal government. Therefore, for instance, as long as molds and yeasts are not accountable to anyone in the medical field can regard such diseases as “idiopathic.” That is, “diseases of unknown origin, cause, and or, cure in nature.” There are very logical and unscrupulous reasons for doing this, and for keeping the American public ignorant of the facts; sorted reasoning called, “money and greed.” Before proving that obstacles of money, greed, and conflicts of interest are motivators for sabotaging current scientific knowledge, it must be established beyond a reasonable doubt, that “science” has in fact established that (especially in relation to respiratory exposures) certain species of live-celled microfungi can and do cause serious diseases in the human body. What is most incredible is that this scientific proof is not hard to find at all. The 107-yearold Merck Medical Manual (17th Ed., 1999) a resource instrument for health professionals states the following: “Opportunistic infections caused by Aspergillus sp and inhaled as mold conidia, leading to hyphal growth and invasion of blood vessels, hemorrhagic necrosis, infarction, and potential dissemination to other sites in susceptible patients… Aspergillus sp are among the most common environmental molds, found frequently in decaying vegetation (compost heaps), on insulating materials (in walls or ceilings around steel girders), in air conditioning or heating events, in operating pavilions and patient rooms….” A list of fungal diseases on Page 1222, Chapter 158, Section 13, of the Merck Manual, demonstrates clearly that 8 of the 11 fungal diseases presented are primarily related to inhalation of various pathogenic molds. And what are some of the fungal diseases identified in this document? The manual lists diseases such as Aspergillosis (as most common), Blastomycosis, Candidiasis (invasive), Coccidioidomycosis, Cryptococcosis, Histoplasmosis, Mucormycosis, etc., all of which are potentially devastating to human health. The Merck Manual also states directly to physicians that: “In immunocompetent patients, systemic mycoses typically have a chronic course. Months or even years may elapse before medical attention is sought or a diagnosis is made. Symptoms are rarely intense in such chronic mycoses, but fever, chills, night sweats, anorexia, weight loss, malaise, and depression may occur.”1 (The Merck Manual, 1999) Evidently, for California scientists employed by the government reading the medical reference manuals of the medical profession is not a forte, nor a requirement of the job. Two aspects of microfungi are clearly evident in human fungal diseases attributed to them. First, is the activity of mold colonization or physical microfungi growth within vulnerable areas of the human body, and second, more importantly, whether these colonies or growths are producing mycotoxins that are poisonous to human cells over time. According to , J., and Klich, M., Department of Cell and Molecular Biology at Tulane University, “Mycotoxins are secondary metabolites produced by micro fungi that are capable of causing disease and death in humans and other animals.”2 (, J., Klitch, M., July 2003) Now, if that is not serious medical science, what is? The most baffling foolery of those who oppose the thought that microfungi have little or no scientific correlation to serious human disease is perhaps that the medical field receives little, if any, formal medical training in the environmental sciences throughout one’s medical career. It is quite interesting that medical science will readily address a live-celled microorganism bacteria as a pathogen, a genetic single or double strand of virus as a pathogenic mutant, but yet constantly address a live-celled microorganism mold or yeast simply as an “allergen.” People are “allergic” to mold allergens! What the medical field fails to realize/recognize is that Botany research clearly demonstrates that pathogenic microfungi are live eukaryotic cells (much smaller, but structurally and chemically very similar to animal and human cells), unlike prokaryotic pathogenic bacteria. All of these microbes are “live cells,” and as people tend to think of “molds” as simply “allergens” or “plant-life” irritants that come and go seasonally, they are not. As Professor Wong explains to his students at the University of Hawaii, Department of Botany, in a class lecture titled, Fungi as Human Pathogens: “The successful treatment of fungal diseases is more difficult than those caused by bacteria. Because bacteria are prokaryotes, the makeup of their cells are very different than our own eukaryotic cells and pharmaceutical products, such as antibiotics, can successfully destroy bacteria without harming our cells, tissues and organs. However, because fungi are eukaryotes, finding a treatment that will kill the fungus and not harm our own cells is more difficult.3” Noted environmental researcher Harriet Ammann, Ph.D., D.A.B.T., a Sr. Toxicologist with the State of Washington, and esteemed member of the Institute of Medicine’s, National Academy of Scientists the explains in her article about cytotoxic micro fungi and their secondary mycotoxins, “Is Indoor Mold Contamination a Threat to Health4” about the health dangers of prolonged indoor exposures: “Mycotoxins… are not essential to maintaining the life of the microfungi cell in a primary way (at least in a friendly world), such as obtaining energy or synthesizing structural components, informational molecules or enzymes. They are products whose function seems to be to give microfungi a competitive advantage over other microfungi species and bacteria. Mycotoxins are nearly all cytotoxic, disrupting various cellular structures such as membranes, and interfering with vital cellular processes such as protein, RNA and DNA synthesis. Of course they are also toxic to the cells of higher plants and animals, including humans. Mycotoxins vary in specificity and potency for their target cells, cell structures or cell processes by species and strain of the microfungi that produces them. Higher organisms are not specifically targeted by mycotoxins, but seem to be caught in the crossfire of the biochemical warfare among microfungi species and microfungi and bacteria vying for the same ecological niche.” The major consequence of not understanding this concept is that government health officials and clever defense attorneys will continue to tell us that pathogenic micro fungi exposed to home, school, and office environments is not unhealthy for people with healthy immune systems. Aren’t these the very same microbes found in hospital environments? It is interesting to note what laboratory protocol medical students and students destined for future laboratory work are being instructed on prior to working with micro fungi in university laboratory settings. In her text, Introduction to Diagnostic Microbiology (1997), Associate Professor and Director of Medial Laboratory Programs, Dannessa Delost, M.S., M.T. (ASCP) of the Department of Allied Health, College of Health and Human Services Youngstown State University5 writes, concerning the health and safety of her students: “Conidia and spores may remain dormant in the air or environment or may be transported through the air to other locations. The spores of pathogenic molds can be inhaled and enter the respiratory tract. This is a common rout of infection, and because of this, it is imperative to practice good laboratory safety when working in mycology. All work, including the preparation of slides, plating and transferring cultures, and nay biochemical work, must be performed in a biological safety cabinet. Because airborne conidia and spores are readily released from a fungal culture, one should never smell a fungal culture. Screw-cap test tubes should be used in place of test tubes with a cotton, metal, or plastic lid. In addition, Petri plates must be sealed tightly with either an oxygen-impermeable tape or Parafilm. As always, gloves should be worn and any breaks or cuts in the skin covered to prevent the transmission of fungal infection.” The confusion over the health effects of long-term exposures to micro fungi might more easily be dispelled in understanding the difference between molds and yeasts that a person breathes in daily, and those species that can and do influence human diseases. Pathogenic (or disease-causing) fungal species are actively involved in releasing mycotoxins (meaning fungus-produced poisons) that are close enough to animal and human cell chemistry to intoxicate these cells. A good example of this activity is observed when a person drinks alcohol; a fungal-yeast produced consumable mycotoxin. Alcohol is a naturally produced product that within minutes after consumption changes neural activity, and generates an adverse accumulative chemical effect on virtually every cell in the human body as the person’s drinking progresses. If enough alcohol is consumed over a short period of time “alcohol poisoning” could result causing a comatose condition in the drinker, or even lead to death. Smoking or chewing of tobacco is also a great example. According to a research study on tobacco released by E. L. Maghraby and M. A. Abdel-Slater of the Botany Department, Faculty of Science at Sohag University in Egypt, titled, Mycoflora and natural occurrence of Mycotoxins in Tobacco from Cigarettes in Egypt6, the following facts relating to tobacco state: “Forty-two species and 4 varieties belonging to 21 genera [of fungal species] were collected from 40 tobacco samples…” The research continues to report that among the many mold species were: Aspergillus, Penicillium, Fusarium, Chaetomium, and Stachybotrys (the so called “Black Mold”) which has been the mainstay of mold reports and civil litigation reported by assorted national and local news media. What is very important as a result of this study is the fact that: “Four samples (out of 40) had toxicity and four compounds of mycotoxins were detected namely; aflatoxin B1, aflatoxin B2, zearalenone, and T-2 toxin,” all of which are known to be associated with lung cancer, liver cancer, birth defects, and other serious diseases. Now, let’s review the definitions of what separate live cellular activity from allergens. Bacteria: Single-celled microorganisms which can exist either as independent (free-living) organisms or as parasites (dependent upon another organism for life). The term bacteria was devised in the 19th century by the German botanist Ferdinand Cohn (1828-98) who based it on the Greek bakterion meaning a small rod or staff. In 1853, Cohn categorized bacteria as one of three types of microorganisms -- bacteria (short rods), bacilli (longer rods), and spirilla (spiral forms). The term bacteria, was preceded in the 17th century by the microscopic animalcules described by Antony van Leeuwenhoek (1632-1723). Mold: A very large group of microscopic fungi that live on plant or animal matter. Most are filamentous organisms and produce spores that can be air-, water-, or insect-borne. Microorganisms: Live cell organisms (forms of life) requiring magnification to see and resolve their structures. " Microorganism " is a general term that becomes more understandable if it is divided into its principal types—bacteria, yeasts, molds, protozoa, algae, and rickettsia—predominantly unicellular microbes. Viruses are also included, although they cannot live or reproduce on their own. They are particles, not cells; they consist of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA), but not both. Viruses invade living cells—bacteria, algae, fungi, protozoa, plants, and animals (including humans)—and use their hosts' metabolic and genetic machinery to produce thousands of new virus particles. Some viruses can transform normal cells to cancer cells. Rickettsias and chlamydiae are very small cells that can grow and multiply only inside other living cells. Although bacteria, actinomycetes, yeasts, and molds are cells that must be magnified in order to see them, when cultured on solid media that allow their growth and multiplication, they form visible colonies consisting of millions of cells. Many people think of microorganisms mainly in terms of " germs " causing diseases, but some " germs " are beneficial to humans and the environment. Disease causing (pathogenic) microorganisms need to be controlled, and in many cases, beneficial microorganisms are also controlled in plant and food production. For thousands of years, people had no concept or knowledge of organisms invisible to the naked eye. In fact, it is only within the last several hundred years that magnification systems (lenses, magnifiers, microscopes) were developed that enabled scientists to observe microorganisms. In 1673 Antoni van Leeuwenhoek, a linen merchant in Delft in the Netherlands, was the first to observe and study microorganisms, using single lenses that magnified objects fifty to three hundred times. The role played by microorganisms was not clarified until the 1830s, when Theodor Schwann in Germany demonstrated that yeasts were responsible for alcohol production in beer and wine fermentations. In 1854, Louis Pasteur in France found that spoilage of wines was due to microorganisms (bacteria) that convert sugars to lactic acid, rather than the alcohol produced by yeasts. He developed the process of " pasteurization, " in which the temperature of food materials is raised to about 140 to 158°F (60 to 70°C), thereby killing many spoilage organisms. Pasteur also discovered that certain bacteria are responsible for the souring of milk. Today, milk is generally pasteurized to reduce its content of microorganisms, to extend its keeping quality, and to protect against pathogenic microorganisms that may be present. Pasteur also discovered that each type of fermentation, as defined by the end products, is caused by specific microorganisms and requires certain conditions of acidity or alkalinity. He discovered further that some microorganisms, the aerobes, require oxygen and others, the anaerobes, grow only in the absence of oxygen. The latter probably developed in the earliest days of the earth when there was no oxygen in the atmosphere. Microorganisms are present in high populations in soil, and in varying numbers in the air we breathe, the water we drink, and the food we eat; they are on our skin and in our noses, throats, mouths, intestinal tracts, and other bodily cavities. They are everywhere in our environment. Allergen: A substance that is foreign to the body and can cause an allergic reaction in certain people. For examples, pollen, dander, mold. (Source: MedicineNet.com at http://www.medterms.com/script/main/art.asp?articlekey=2194) Now let’s observe separate live animal and mold/yeast (eukaryote) cell structures as opposed to bacteria (prokaryote) structure. The virus is not a live cellular structure, but strings of DNA/RNA that require a live human, animal, mold, bacteria, tree, or plant cell to latch onto in order to formulate life. In the “Tree of Life,” note where live bacteria cells are recorded as opposed to live mold/yeast cells. Many of animal cell traits are similar to those found in and of microfungi cells. Bacteria could not be more distant from animal cells whereas live fungi are right below animal cell development. It is no wonder why mold and yeast cells are difficult to detect in blood and tissue, they have the ability to mimic human cells and remain undetected in disease processes while bacteria are readily detectable by human immune system chemistry. Note below how close in chemical structure animal-produced cholesterol is in correlation with microfungi-produced ergosterol. This demonstrates clearly how nearly identical cellular chemistry is between and interactively in animal and microfungi live cells. With this said, let’s observe a direct process of microfungi decomposing activity while a person is still alive. The following medical case image directly relates the serious damaging rampage of certain Aspergillus species in the Cerebral Cortex as observed in a formerly critically ill patient, now deceased. (Source: http://brighamrad.harvard.edu/Cases/bwh/hcache/334/full.html) The question is, could this same health problem exist in a patient who is considered immune competent, or otherwise considered physically healthy? For that answer on your computer visit the following website address: (http://www.ajnr.org/cgi/reprint/26/4/835.pdf) Immune competent patients in hospital facilities where construction is in progress, or where air ventilation systems are defective have been known distribute pathogenic molds such as the Aspergillus fumigatus species that can and do cause an immune competent patient to become seriously ill. This is called a “nosocomial” (i.e., hospital caused) or related illness, and it happens quite frequently, more so than previously thought less than a decade ago. Can exposures of microfungi in the lungs lead to serious neurological (brain) diseases and disorders? Most medical professionals will tell you that this occurs primarily in patients that are diagnosed as critically ill already, but without any requirements for state or federal mandated reporting of fungal diseases it is anyone’s guess how great of a serious health threat this is. One thing is absolutely sure with this photograph, and it is that this is clear evidence that molds can and do, cause neurological diseases through exposures. How else would a patient’s brain end up as in this picture without having been exposed to microfungi in some specific manner? We do know that alcohol consumption can lead to neurological and many other deadly disorders. So, why would someone want to keep the general public misinformed as to the prospects of serious diseases and microfungi? Let’s direct our attention to one such company that has generated a great deal of interest to this regard, and surprisingly who the research they generated was directed to, and for what reasons. A January 9, 2007, a front page Wall Street Journal article titled “Court of Opinion: Amid Suits Over Mold, Experts Wear Two Hats” authored by Armstrong rekindled a longstanding battle over the American College of Occupational and Environmental Medicine (ACOEM) society’s solicitation of a document titled “Adverse Human Health Effects Associated with Molds in the Indoor Environment” authored by a former highly-ranked government health official. People who have been suffering from what they say are health issues caused by indoor mold exposures, and several of the medical doctors who treat them are upset, indicating that this document, now used as the ACOEM’s “Position Paper” is “seriously flawed.” Charges of manipulation of scientific research, favoritism, and conflicts of interest, were just a few of the comments that began to heat up many Internet “chat boards” such as “ToxLaw.com” and ’s, “Sickbuildings”. The noose was tightening for the ACOEM should any of the things these public health watchdog were actively discussing prove true. It would literally spell disaster for this society’s predominate association of Workman’s Compensation Certified Medical Examiners boasting a membership of more than 5,000 physicians, if the public were to lose faith in the quality of medical authority this society claims to exemplify. An example of what is at stake is offered in an article titled, “Texas Picks ODG over ACOEM”, authored by Jim Sams, Senior Editor of an Internet news service provider, “WorkCompCentral.” This article states that, “The state of Texas on September 1, 2006, selected the Work Loss Data Institute’s (WLDI), “Official Disability Guidelines” over the guidelines submitted by the ACOEM.” Work Loss Data Institute president, Phil Denniston stated publicly that he believes, “Officials saw that the Work Loss Data Institute—a private company—has the only set of guidelines that are adopted by the federal government’s medical guideline clearing house.” Executive Director of the ACOEM, Barry Eisenberg, immediately took issue with this. In a written statement issued after Texas posted its proposed rule, Eisenberg states, “We would hope that Texas would at a minimum allow physicians to use a set of treatment guidelines developed by the medical profession rather than mandating the exclusive use of guidelines developed for commercial purposes.” The “WorkCompCentral” article continues, “But in California, proposed rules that would make ACOEM the exclusive source of treatment guidelines were widely criticized by medical specialists during an August 23 public hearing. They said the ACOEM does not address chronic conditions and has many other gaps that cause unnecessary disputes between physicians and insurance carriers.” Quoting Steve Cattolica, Government Affairs Director for the California Society of Industrial Medicine and Surgery, the article stated that, “…he hopes Texas’ decision will alert California DWC officials that they should look beyond ACOEM.” California did not, and the history that followed accepted the ACOEM’s guidelines. With huge potential revenue at the heart of this competitive slugfest, a major violation of ethics or improprieties could be catastrophic. In response to the Wall Street Journal article, on January 13, 2007, Tee L. Guidotti, M.D., MPH, current President of the ACOEM issued the following statement, “What is lost in the WSJ article is the technical accuracy of the statement. The contentious issue at hand is not damp spaces or the association of mold and mold spores with allergic, infectious, or irritating conditions. It is whether the metabolic products of mold known as mycotoxins, absorbed through biological particle inhalation in indoor air, is responsible for systemic human disease under conditions encountered in normal life, an unproven theory called “toxic mold” in the vernacular. The weight of evidence to date, despite years of investigation, does not support that it is and seems unlikely to shift with new findings.” Unfortunately, Dr. Guidotti failed to comprehend the objective of the WSJ article. It had little to do with scientific findings, and a great deal to do with the perceived impression that the ACOEM in effect is using perceivably contrived and distorted facts of “rat study” science as the ACOEM’s official position on “mold exposures and illness.” The ACOEM official position on molds and health is potentially full of alleged ethics violations, conflicts of interest, and selective manipulation of science on a grand scale! It threatened to destroy the integrity of the ACOEM and gravely harm many victims of such exposures living and working in unhealthy mold infested and contaminated homes, schools, and office buildings. For the president of the ACOEM to blatantly offer that the science is not available to support current medical knowledge, is to claim absolute ignorance of the facts. The facts are that apparently the medical community has chosen to ignore the facts that hospital environments have been failing to effectively diagnose and or treat and all but ignore for nearly 100 years of available scientific study. On December 7, 2006 the California Division of Worker’s Compensation (DWC) published several intended modifications for incorporation into the state’s “Medical Treatment Utilization Schedule (MTUS) regulations. California ultimately did elect to use the American College of Occupational and Environmental Medicine’s (ACOEM’s) “Occupational Medicine Practice Guidelines: Evaluation and Management of Common Health Problems and Functional Recover in Workers”, 2nd Ed., as its guideline for evaluating work-related illnesses and injuries. What the ACOEM Board of Directors also elected to do prior to the California endorsement of their guidelines is on October 27, 2002, commission and accept a paper entitled “Adverse Human Health Effects Associated with Molds in the Indoor Environment” as the society’s “official position” on indoor mold exposures and human health. This gives one great pause in wondering if the California DWP didn’t level a “snow-job” on the unsuspecting California worker, either by profound ignorance or simply through unscrupulous collusion! The fact is that the supportive science data used as references for this supposedly “peer-reviewed” document were intimately examined as one would expect from a prestigious medical body claiming itself as a “College” academic entity. There is little evidence for that matter, to indicate that this document was ever adequately reviewed by the ACOEM “rank-and-file” as a whole. To ascertain why this practice is wholly unacceptable, one needs only to understand the scope of influence that exists between the ACOEM and government, and within the medical community. There are two extremely important proposed changes to California’s MTUS regulations under §9992.20, the “Medical Treatment Utilization Schedule”, that pose to significantly impact California workers facing the unfortunate prospects of an illness or injury suffered while at work. The first statement that was added changed: “(d) “Evidence—based” means based, at a minimum, on a systematic review of literature published in medical journals included in MEDLINE.” From, a now deleted statement: “(g) “Hierarchy of evidence” establishes the relative weight that shall be given to scientifically based evidence.” At first glance these two changes do not mean much. However, under further examination they speak volumes as to “what stinks,” in the state of California! And that is precisely what is happening! Simply stated, if “scientific evidence” is eliminated in favor of a “systematic review” of literature published in assorted medical journals, California’s workers might not be examined based on “facts of medical science.” In some clinical situations this could spell disaster in misdiagnoses, delayed critical medical treatment decisions, and the timely distribution of appropriate workman’s compensation benefits. It is said, that the proposed changes will resolve the conflict between the interpretation of Labor Code 5307.27, mandating that any treatment guideline be “evidence based, peer-reviewed, nationally recognized standards of care,” and the ACOEM philosophy of majority-rules “consensus based” standards. The ACOEM’s “consensus based” peer-reviewed study for example in determining illnesses related to a single “rat study” associated with work-related mold exposures could prove costly to American workers. To support this contention and demonstrate more clearly how the ACOEM’s “consensus” on mold-related health issues was attained, one needs only to follow how the authors of the “Adverse Human Health Effects Associated with Molds in the Indoor Environment” ACOEM Position Paper were able to literally bypass scientific “peer-review” by the ACOEM membership in producing a “consensus-approved” document. To comprehensively understand why the ACOEM medical body might want or need a report effectively denouncing mold exposures as a viable health problem in the worker, we must revisit a 1994 medical research study conducted by the Centers for Disease Control and Prevention (CDC) at the Children’s and Baby’s Rainbow Hospital in Cleveland, Ohio. In 1993, Dorr Dearborn, a pediatrics medical doctor at Rainbow Hospital began to encounter an unusual outbreak of pulmonary hemorrhage in several infants, all of which were less than six months of age. The CDC dispatched two of its senior researchers, Ruth Etzel, M.D., PhD, and Barbara Bowman, PhD to investigate. Researchers tied a dangerous mold identified as Stachybotrys chartarum growing in the homes to the sick infants. This incident increased public awareness of home/building molds to the degree that the Learning Channel produced a documentary of the study. National news networks began to report this story and soon this fungus began to surface as an environmental health problem throughout the nation. By 1999, more than 11,000 litigation cases had been filed, and scores of people were flocking to attorneys claiming to have been injured by indoor mold exposures. In the “lessons-learned” category, Americans observed quickly in New Orleans after hurricane Katrina all but destroyed the city, that the true purpose of government agencies might not be designed so much as to protect humans and preserve life as they are to protect and defend the American economy in times of trouble. Perhaps this was the motive behind the CDC’s release of a Morbidity and Mortality Weekly Report (MMWR) on March 10, 2000 stating that, “A review within CDC and by outside experts of an investigation of acute pulmonary hemorrhage/hemosiderosis in infants has identified shortcomings in the implementation and reporting of the investigation described in MMWR and detailed in other scientific publications authored, in part, by CDC personnel. The reviews led CDC to conclude that a possible association between acute pulmonary hemorrhage/hemosiderosis in infants and exposure to molds, specifically Stachybotrys chartarum, commonly referred to by its synonym Stachybotrys atra, was not proven. This report describes the specific findings of these internal and external reviews.” This MMWR report sparked an immediate rebuttal from the original research team including doctors Dearborn and Etzel, stating “…the internal and external review reports summarized a great deal of thoughtful discussions by these two groups. However, neither review group included any member of the initial study team and neither review group visited Cleveland to see the buildings or talk to the families, community groups, Cuyahoga County Health Officials and building inspectors, nor the physicians at the Rainbow Babies & Children's Hospital.” Dr. Etzel was upset enough with this rebuttal that she left the CDC expressing her displeasure in a July 26, 2000 interview with Mark Moran, MPH, then with WebMD, “Tom Sinks, PhD, a CDC epidemiologist, says that when the agency responds to an urgent request for an investigation, its mission is to rapidly assess a situation, not to do long-term research. " We do not have the luxury in these situations to do the most exquisite type of research, " he tells WebMD. " Our purpose is not to start something we can't finish. " Sinks says the CDC recognizes the link between mold and human health, and urges people to take preventive action when there is water damage in the home. But regarding a connection between stachybotrys and hemosiderosis, the evidence is too weak to justify policymaking, he says. That conclusion generated controversy about the way the CDC handled the case. Ruth Etzel, MD, an epidemiologist formerly with the CDC who headed the original study, says the agency's review of the work is " dead wrong " and that the CDC has sought to bury the connection between mold and disease. " Normally, when a new idea is presented, you do more work and test it further in other places, " says Etzel, who says she left the CDC as a result of the controversy and is now director of the division of epidemiology and risk assessment at the food safety and inspection service of the USDA. " What happened here was that instead of moving forward, a decision was made to put a stop to our work. " She says the current scientific consensus on the dangerous health effects of mold stems largely from the Cleveland study. " Previously, most physicians thought of mold as quite innocuous, " she tells WebMD. " We were able to focus on mold in a way that the medical world had never done before. " Since that report was published, several medical doctors who have been treating patients for symptoms related to indoor molds have faced the scrutiny of state Medical Boards with board efforts to revoke their medical license. One California physician actually lost his medical license in 1998 as a result of unfounded accusations that he had been illegally treating his patients inconsistent with “standard medical practice” for non-existent fungal diseases. In February 2005 this doctor’s medical license was reinstated and he was fully exonerated. However this was too late, his medical practice was literally ruined; his credibility was publicly crushed and he was outwardly humiliated; and the accumulation of legal fees cost him hundreds of thousands of dollars. How does this happen, one might ask? It is fairly easy actually. The state Medical Board or the CMS receives an anonymous complaint, and under complete confidentiality without disclosure of the person(s) who lodged a complaint. The investigation is conducted because a complaint has been lodged. While the person or corporation complained about is publicly scrutinized and humiliated as guilty without trial, the person who lodged the complaint, whether meritorious or not, throughout the investigation, hearing, or trial is never disclosed to the defendant. Now sarcastically speaking, that is truly American justice at work! If we were to quiz every medical doctor or scientist who has ever studied certain species of live-celled gram-negative and positive bacteria or various viruses to any degree as to whether studies behind the health issues related to these microbes are considered “junk science”, the answer would certainly be, “Of course not! There is solid scientific evidence to support their pathogenicity as fact.” Yet, we have pathogenic micro fungi (live cellular pathogens), clearly observed as environmentally, physically, and subtly much more diverse and destructive than many other microbes, and suddenly because there is so much more economically and politically at stake, the research involving the health issues behind indoor exposures in a court of law are made out by the defense experts as “junk science!” Our involvement in the study of the “brave new frontier” of Molecular Science has been active for nearly 35 years, and with the current genetic studies of various micro fungi are being realized medically as much more frightening to deal with. Unlike bacteria, micro fungi are much more diverse as pathogens and are “primary” decomposers. These microbes are far superior to bacteria and viruses in their physical composition and how they perform metabolically to conform to, and destroy, any prey in their quest to survive in a hostile world. We allege that if there is any “junk science” relative to the study of micro fungi and their physiologic connection with animal and human illness, it belongs to the illogical antics by defense experts. Which brings us back to the focus of this article as it relates to California’s proposed MTUS acceptance of the ACOEM Occupational Medicine Practice Guidelines in the evaluation and management ill or injured workers. Recalling Dr. Ruth Etzel’s parting shot that, “The CDC has sought to bury the connection between mold and disease…” is extremely important! Why? Because Dr. Etzel’s statement offers a direct link to one of the primary “defense experts” of VeriTox, Inc., Hardin, PhD, who along with Bruce Kelman, PhD, in conjunction with Saxon, M.D., of the UCLA Medical Center authored the ACOEM’s Position Paper. Dr. Saxon’s connection with government is that he receives grants from federal entities such as the National Institutes of Health, which the CDC falls under. According to information on the VeriTox, Inc. website (a company with litigation experts known for their defense antics in providing expert testimony for the purpose of dissuading juries from accepting the idea that exposures to indoor molds infestations and contaminants lead to serious human health problems), one of its principals and an author of said paper Hardin, PhD, FATS, " …was commissioned into the US Public Health Service and began his public health career with the National Institute for Occupational Safety and Health (NIOSH) in 1972, where he served in research, policy, and management roles, culminating as Deputy Director of NIOSH and Assistant Surgeon General in the Public Health Service.” To say that Dr. Hardin does not have intimate connections at high levels of government including the CDC, would be a grave misstatement. To believe for an instant that many of the medical doctors most influential in the ACOEM position paper do not also have similar political connections, would also fail a scrutiny test. How was this position endorsed if the voting membership of the medical college that is not a true college were not given a proper chance to review the research behind it? That is in itself an interesting story, and is the “primary” reason that a “consensus” philosophy over a “scientific evidence” philosophy as promoted by the California Worker’s Compensation Institute, would not be feasible in evaluating the health and injury guidelines of ACOEM, guiding Qualified Medical Examiners (QMEs) as currently managed. Another manner in which to address this is how can California trust an ACOEM society of medical doctors to set guidelines for one of the most important entrustments between employee and employer, if the California DWC approves “unscientific” and “shabby” medical science for implementation as part of its guidelines covering various work-related illnesses and injuries nationwide? The California Workman’s Compensation system would greatly injure the California worker should this unwise indiscretion occur. The American Academy of Allergy, Asthma and Immunology (AAAAI) recently received major complaints from alert members who are keenly aware of the misgivings of the VeriTox, Inc., authored report as it was proposed for the AAAAI Position Paper in response to indoor mold exposures and health. To provide credibility for this Guest Editorial article, on May 1, 2006 in Harold v. California Casualty Insurance Company in Sacramento Superior Court, Case No. 02AS04291, Judge P. Kenny, in ruling on the “/Frye” admissibility of scientific merit and admissibility of testimony by Coreen A. Robbins, PhD, MHS, CIH, on in behalf of VeriTox, Inc., as one of its defense experts and corporate principals, an inadmissibility ruling was rendered. The purpose for a New York state-based, -Frye hearing is to allow the judge acting as a “gatekeeper” for the integrity of the court and or trial process, to preclude any “non-science” or “junk science” based testimony or evidence from being introduced into the trial proceedings as evidence. In the “Harold” case, the objective of Judge Kenny’s “-Frye” hearing was to rule as to the admissibility of a “single rat clinical study” addressing the “dose-response” relating the findings of this study to indoor mold hazards and human illness. Judge Kenny decided not to allow Dr. Robbin’s testimony based on his review of the following documents: 1) “Risk from Inhaled Mycotoxins in Indoor Office and Residential Environments” International Journal of Toxicology 2004; 23: 3-10. Authors: C.A. Robbins, L.J. Swenson, and B.D. Hardin. 2) “Adverse Human Health Effects Associated with Molds in the Indoor Environment” Journal of ACOEM 2003. ACOEM “Mold Position Statement” Authors: B.J. Kelman, B.D. Hardin, and A.J. Saxon. 3) “The Medical Effects of Mold Exposure” American Academy of Allergy, Asthma and Immunology (AAAAI) “Mold Position Paper”. Authors: R.K. Bush, J. Portnoy, A. Terr, A.J. Saxon and R.A. Wood Judge Kenney ruled to preclude any reference or testimony relative to these published documents during the “Harold” trial by reasoning in his words, that: “When I reviewed the DHS report from April of 2005, DHS, Department of Health Services was talking about the fact that they were unable to establish personal exposure levels at this point in time based on a lack of sufficient information, and yet Dr. [Coreen] Robbins [a Principal of VeriTox, Inc.] is asking to take an even greater step and go beyond establishing, for example, a personal exposure level and jump to modeling, which is far more tenuous and far more unreliable even in establishing something that is as hard as a personal exposure level. So those are the difficulties I’m having with Dr. Robbins’ testimony.” Judge Kenney further commented that: 1) “…He is familiar with the use of animal studies and derivative models for humans and that such models are commonly accepted in the scientific community” Also, “…I am not sure such models for mycotoxin exposure would pass a -Frye test for admissibility.” 2) “My fundamental problem is in looking at it from a Frye standpoint I just didn’t see kind of acceptance in the scientific community with regard to what she [referencing, Dr. Coreen Robbins] that would allow it to be sort of presented as such.” 3) “Modeling has severe limitations, and one of the difficulties I was having here was this reliance upon animal studies to jump to a modeling conclusion generally with—again, I’m speaking from my own experience because there is nothing here in this transcript—generally one will use the data that one can receive either from animal exposure studies or other information to then input in a model to make a determination with some degree of reliability.” Further, “Here I am not hearing any of those things. I’m hearing essentially this jump from literature review to a postulated model to a no harm result.” If a Superior Court judge was wise enough to see through the “unacceptable” scientific merit of a single “rat study,” why then didn’t the officers of the ACOEM, a supposed “College” of a “Society” composed of over 5,000 highly-trained medical doctors? The answer lies in politics and not medicine. A great deal is at stake both medically speaking, and in the realm of pure economics. There are few products supported by bacteria or viruses. However, there are literally thousands of products that either include fungal-produced mycotoxins used for flavor, scent, or other characteristics and attributes that are unhealthy to humans over time. There are molds and mycotoxins that are not healthy for human consumption but cannot be extracted or controlled by current scientific methods. If the American public actually grasped the enormity of this fact, and that of mold species implications in “idiopathic” (or, of “unknown cause or unknown cure”) diseases, the research and effective counter-treatments costs alone, would be prohibitive. The human populations most adversely affected by mold exposures are infants under the age of two and people over the age of fifty. It is not a secret that the success of Health Maintenance Organizations (HMO), and similar health plans depends on “preventive medicine” as opposed to “treatment and/or therapeutic medicine.” As long as diseases related to mold exposures do not have to be recognized or recorded medically, there is virtually little or no liability; not in medicine… not in food processing… not in real estate… not in much of anything commercially! In accepting the “Adverse Human Health Effects Associated with Molds in the Indoor Environment” report as the authority for the ACOEM position on indoor mold exposures authored by B.J. Kelman, B.D. Hardin, principals of VeriTox, Inc., in conjunction with Dr. A.J. Saxon, of the UCLA Medical Center, one has only to peer through the veil of ACOEM membership solicitation to understand its objective for producing an anti-mold exposure aversely affecting human illness, position statement.” The ACOEM is involved in assisting government in establishing “National Policy.” For one to belong to this vast organization is prestigious enough, but to be brought into this “society” of medical doctors for the specific purpose of authoring a medical “Position Statement” is huge! For once accepted as gospel, this unorthodox document would have far-reaching and extremely strong political and fiscal implications at its core. A former Assistant Surgeon General with NIOSH/CDC, Hardin, PhD, then a Principal of GlobalTox, Inc. (renamed as VeriTox, Inc.) was asked by ACOEM administration to draft a Position Statement for consideration by the college. Knowing that any author of an ACOEM Position Paper should accordingly be a member of the ACOEM, in February 2002 Dr. Hardin was provided with a free membership in the ACOEM. It is alleged that this perk served as an “advanced thank you” for writing the ACOEM Position Statement. Prior to Dr. Hardin’s acceptance for membership into the ACOEM, this organization was open to “physicians only” after his induction, this so-called “College” is now open to practically anyone with who is able to pay its membership dues. A memo written to member Dean Grove, with copies also sent to J. Bernacki, M.D, MPH, Barry S. Eisenberg, ACOEM Executive Director, and ACOEM President J. Key, M.D., MPH, FACOEM, by Borak, M.D., FACOEM, Chairman of the ACOEM Committee on Scientific Affairs stressing the significance of the Position Paper stated, “Dean et al: I am having quite a challenge in finding an acceptable path for the proposed position paper on mold. Even though a great deal of work has gone in, it seems difficult to satisfy a sufficient spectrum of the College, or at least those concerned enough to voice their views. “I have received several sets of comments that find the current version, much revised, to still be a defense argument. On the other hand, Hardin and his colleagues are not willing to further dilute the paper. They have done a lot, and I ma concerned that we will soon have to either endorse or let go. I do not want this to go to the BOD and then be rejected. That would be an important violation of —I have assured him that if we do not use it he can freely make whatever other use he might want to make. If we “officially” reject it, then we turn his efforts into garbage. “As this was an effort that you, Dean, asked me to initiate I thought that you might have a good idea about what might be done. “The problem is the same as when this began. Mold is a litigation mine field. Everybody involved in the topic has a strong view and there is little middle ground. If we have a statement that deals only with science, we will be accused of ignoring the “Public Health” issues. If we embrace the Public Health, then we will be regarded as not scientific. “I have not previously been involved in an ACOEM issue that raised provoked emotions among member peer reviewers. My own feeling is that it may not be worth the disruptive effects that might result from forcing the issue. Also, I think that the authors are not willing to let this just sit for awhile. They have done a lot of work and want to see it in print. “For your interests, I have attached the latest version. ” This memo tends to observe that a few of the decision-makers within the ranks of the ACOEM were concerned primarily with Dr. Hardin and the position paper’s other authors, and not with the quality of medical care of working public. One of the three documents submitted for evidence to Judge Kenny observed as based upon inadequate scientific study was titled, “The Medical Effects of Mold Exposure” authored by J. Portnoy, A. Terr, A.J. Saxon and R.A. Wood. What is not publicly discussed by administrative members of the AAAAI about this document (the association’s adopted position on mold exposures) called the “Bush” paper, is that it generated a massive response from people with intimate knowledge about the realities of mold exposures and illness. After a series of complaints demanding its retraction as published in the Journal of Allergy and Clinical Immunology (JACI), one of its authors, Dr. Portnoy, pulled his name from “co-authorship” in protest against the abuse of academic process by the remaining authors. Dr. Saxon, one of the primary authors of the ACOEM position paper was intimately involved in the AAAAI document. In a rebuttal statement to the initial AAAAI position statement titled “Rigor, Transparency Disclosure Needed in Mold Illness Position Paper” published in the September 2006 issue of the JACI, co-authored by noted physician Ritchie Shoemaker, M.D., Harriett Amman, Ph.D., DABT (a distinguished member of the National Academy of Sciences), Lipsey, PhD, and W. Montz, Jr., PhD, CIHQP, the integrity of scientific research was discussed. The rebuttal states, “Over 100 MDs and PhDs from the mold community, demands proper disclosure of conflict of interest and thoroughness from papers written by defense-hired physicians. Both the ACOEM “opinion” and the AAAAI statement show no such rigor, transparency, and disclosure. One should wonder how such junk science, as labeled in a California ruling (Harold v. California Casualty No. 02AS04291), based on bizarre leaps from one study of acute, high-dose exposure to unknown mycotoxins in rats to and even more bizarre conclusion about absence of human illness associated with chronic, low-dose exposure to water-damaged buildings, cited repeatedly by a small cadre of non-treating physicians {two of the three authors of the ACOEM position paper are PhDs and are not physicians} for possible financial gain, could ever be considered by anyone as acceptable.” In summary, until the ACOEM strives to rely on factual medical science how can anything this supposed “college” sets as guidelines in evaluating medicine be relied upon to any degree in California? What the ACOEM guidelines might perhaps suggest to California workers is that the California Workman’s Compensation system is not truly concerned for the health, safety, and personal welfare of the worker inasmuch as it is in ensuring that the economic status of California continues to prosper irregardless of what is factual or not within the realm of medical science. The California worker pays some of the highest taxes in the nation for its legislators. The question here is, with the lack of government scrutiny in accepting ACOEM guidelines as demonstrated in this article, what are taxpayers actually paying for? Until the ACOEM regain an acceptable status of reliable public trust and credibility, California is encouraged to eliminate its use of the guidelines set-forth by the ACOEM. There is far more to this story than one could possibly cover in a condensed article. However, with what has been offered, the challenge is for California government to reinvestigate this matter much more thoroughly, and deal with the findings to the full satisfaction of the public at large. References: Merck Manual, The. 17th Ed. (1999) “Systemic Fungal Diseases” (Systemic Mycoses). Chapter 158, Page 1210. , J. W., Klich M. (July 2003). Mycotoxins. Clinical Microbiology Reviews, Vol. 16. No. 30893-8512/03. American Society for Microbiology (p. 497-516) Retrieved October 26, 2004 at http://www.cmr.asm.org/cgi/content/full/16/3/497 Webster’s Ninth Collegiate Dictionary (1988). Page 783. land Department of Health & Mental Hygiene, Community Health Administration (1999). Guidelines for Prevention and Control of Nosocomial Pulmonary Aspergillosis. Retrieved August 9, 2005 at http://edcp.org/guidelines/aspers2.html Delost, D. M. (1997). Introduction to Medical Mycology. Introduction to Diagnostic Microbiology: A Text and Workbook. Mosby, St. Louis, MO. 358 Ammann, H.M. (February 2001, Updated September 2003). Is Indoor-Mold a Threat to Human Health. Washington State Department of Health, Office of Environmental Assessments. Retrieved March 14, 2004 from http://www.allergyconsumerreview.com/mold-and-mildew-allergy.html National Academy of Sciences (May 25, 2004). News Release: “Indoor Mold, Building Dampness Linked to Respiratory Problems and Require Better Prevention; Evidence Does Not Support Links to Wider Array of Illnesses”. Retrieved on August 10, 2005, from http://www4.nationalacademies.org/news.nsf/isbn/0309091934?OpenDocument MedicineNet.com at http://www.medterms.com/script/main/art.asp?articlekey=13954 MedicineNet.com at http://www.medterms.com/script/main/art.asp?articlekey=4416 Moran, M. (July 26, 2000). Environmental Health Watch: Healthy House. WebMD Medical News. Retrieved on April 16, 2003 from http://www.ehw.org/Healthy_House/HH_Toxic_Mold.htm ACOEM (October 27, 2002). Adverse Human Health Effects Associated with Molds in the Indoor Environment. ACOEM Evidence-based Statement. American College of Occupational and Environmental Medicine. Retrieved on August 10, 2005, from http://www.acoem.org/guidelines/article.asp?ID=52 Cockrill, B. A., Hales, C. A. (February 1999). Allergic Bronchopulmonary Aspergillosis. Annual Review of Medicine, Vol. 50: 303-316 (Volume publication date February 1999) (doi:10.1146/annurev.med.50.1.303), Pulmonary and Critical Care Unit, Partner's Asthma Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114. Retrieved on August 10, 2005 from http://arjournals.annualreviews.org/doi/abs/10.1146/annurev.med.50.1.303?journal\ Code=med , G.M., Perfect, J.R. (October 31, 2003). Fungal Sinusitis. Uptodate Patient Information. Retrieved on August 10, 2005, from http://patients.uptodate.com/topic.asp?file=fung_inf/5646 Lacey, J., Dutkiewicz J., (March 1994). Bioaerosols and Occupational Lung Disease. Institute of Arable Crops Research, Rothamsted Experimental Station. Journal of Aerosol Science, Vol. 25. No. 8, Page 1371 Jarvis, B. (1995). Mycotoxins in the Air: Keep Your Buildings Dry or the Bogeyman Will Get You. International Conference: Fungi and Bacteria in Indoor Environments, Health Effects, Detection and Remediation. Eckardt Johanning, Chin S. Yang, editors. Saratoga Springs, NY Ecohealth Environmental Change and Our Society: Glossary. Retrieved July 28, 2005 at http://www.ecohealth101.org/glossary.html The American Heritage® Dictionary of the English Language, Fourth EditionCopyright © 2000 Published by Houghton Mifflin Company. Retrieved on July 28, 2005 at http://www.emc.maricopa.edu/faculty/farabee/BIOBK/BiobookglossE. html Retrieved on July 28, 2005 at http://www.emc.maricopa.edu/faculty/farabee/BIOBK/BiobookglossPQ. html Retrieved on July 28, 2005 at http://www.enchantedlearning.com/subjects/butterfly/glossary/indexed.shtml Margulis, L., Sagan, D. (1996). Microbial Microcosm. Retrieved July 28, 2005 at http://www.context.org/ICLIB/IC34/Margulis.htm Fox S.W. (May 12, 1997). My Scientific Discussion of Evolution for the Pope and His Scientists. Retrieved July 28, 2005 at file://C:\DOCUME~1\DOUGLA~1\LOCALS~1\Temp\9BY8TCYV.htmADDITIONAL IN RESPONSE TO THE JOHNS HOPKINS ARTICLE: " Mold Myths " 1. Challenge: Name the " common molds " that do not hold up under scrutiny? Answer is: Approximately 400 molds are known to have some definite interaction with animals and humans involving anything from being irritants to cancer causing. More common molds often observed indoors, such as variants of the Penicillium species fall into that category, as do species of Alternaria, Aspergillus, Rhizopus, Fusarium, Stachybotrys, or many others mentioned in my book, " Toxic Mold! Toxic Enemy! " View the section below for others: (I'm definitely not afraid to name some of them.) FUNGI: HEALTH INFORMATION NOTE: 1) Common Disease Causing 38 Species (Underlined) 2) Allergy Causing 21 Species (marked as “++”) *Counts of species are based on the genome only (i.e., Aspergillus (only a few of the over 180 are listed herein), Penicillium, Fusarium, etc., many of these genome have multiple subspecies that may cause equal or severe health problems through skin contact, inhalation, and food intake. It is estimated that over 300 such subspecies exist affecting human health. Fungi Descriptions And Health Concerns The following descriptions represent the most common fungi species found in buildings and in which may be found in animals and humans exposed to environmental fungi contamination. This does not represent a comprehensive listing of all fungi genera or the secondary chemicals (mycotoxins) they produce and excrete. Absidia sp. - Reported as an allergenic pathogen. This species is known to cause mucormycosis (infection of invaded tissue) in immune compromised persons. Infection may have multiple sites. Infection sites are: brain, eye, lung, nasal sinus, and skin. Acremonium sp. (Cephalosporium) - Reported as an allergenic pathogen and is the asexual state of Emericellopsis sp., Chaetomimum sp., and Nectripsis sp. This fungus is observed to cause mycetomas (cornea and nail infections). Can produce Trichothecene mycotoxins if inhaled or ingested. High-level exposure can cause diarrhea, nausea, and vomiting. Alternaria sp.- Alternaria is a common allergenic pathogen often found in carpets, textiles, and on horizontal surfaces of building interiors, and in window frames. Spores from this species normally are deposited in the nose, mouth, and upper respiratory tract. Alternaria is associated with Baker’s asthma and hypersensitivity pneumonitis. Alternaria alternaria sp. – A variant of Alternaria sp. that is capable of producing Tenuazonic Acid and other mycotoxin metabolites associated with animal and human disease. It is known as a common cause of extrinsic asthma intermediate-type hypersensitivity (Type 1). Acute symptoms: bronchia spasms, edema, and in chronic cases the development of pulmonary emphysema. Aspergillus sp. – Many of the Aspergillus species produce several secondary chemical mycotoxins that are associated with diseases in animals and humans (e.g., various cancers, liver disease, splenomegaly, etc.). Mycotoxin (esp. Aflatoxins) production is dependent upon the species or a strain within a species and the nutritional source particular for the specific fungal species. Currently, there exist over 200 subspecies of this genera type. This species is also reported to be the cause of extrinsic asthma (immediate, or acute-type hypersensitivity [Type I]). Acute symptoms include edema (joint or tissue swelling), and bronchia spasms (chest pain). In chronic cases, pulmonary emphysema (major bronchial/lung damage) is often presented. Aspergillus caesiellus sp.– A species occasionally pathogenic in animals and humans. Aspergillus candidus sp. – A species associated with respiratory complaints. Can produce Patulin, a mycotoxin associated with disease in both animals and humans. Aspergillus clavatus sp. – A species that is normally not found indoors but is found in soil and animal manure. It is known to produce Patulin, a mycotoxin associated with disease in animals and humans. Aspergillus deflectus sp. – A species occasionally pathogenic in animals and humans. Aspergillus flavus sp. – A species that is known to produce highly carcinogenic Aflatoxin mycotoxins when inhaled or ingested affecting both animals and humans. It may also result in occupational disease via inhalation. It is tetraogenic and mutagenic, and highly toxic to the liver. It is known to be allergenic, with its presence often associated with asthma and other forms of respiratory ailments. This species is strongly associated with aspergillosis of the lungs and or disseminated aspergillosis (diseases of multi-species of the Aspergillus fungi). It occasionally is known to cause corneal, otomycotic (fungal ear), and nasoorbital (nasal cavity) infections. In indoor environments it often is found in water-damaged carpets. The production of its mycotoxins is dependent on the growth conditions conducive to its terrain and the substrate (nutrients) used as food sources. Aspergillus fumigatus sp. – A species identified as a major cause of aspergillosis that is both allergenic and invasive and is known to be pathogenic in both immune-competent and immune compromised persons. It is often found in outdoor compost piles and on some breakfast cereals. Aspergillus glaucus sp. – A species that is observed as a common outdoor fungus in the winter. It is known to be allergenic and occasionally pathogenic to both animals and humans. This species is also known to contaminate leather, and can grow at low moisture levels on grains, sugary food products, meat and wool products. Aspergillus nidulans sp. – A species normally found in mild to warm soils and on slowly decaying plants that is observed as occasionally pathogenic to animals and humans. It can produce the mycotoxin Sterigmatocystin, that is observed to cause kidney and liver damage in laboratory animals. It is associated with aspergillosis of the lungs and or disseminated aspergillosis. Aspergillus niger sp. – This is a species identified by a strong musty odor associated with pulmonary disease in immune compromised persons. It is also known to cause some forms of skin infection. Aspergillus ochracus sp. – This species is found in grains, soil and salted food products. It is known to produce the mycotoxin Ochratoxin A, which affects the kidneys (also known as Balkan neuropathy). Ochratoxin is also is produced by other Aspergillus Sp. and Penicillium Sp. Other mycotoxins that can be produced by this fungus include Penicillic Acid, Xanthomegnin and Viomellein. All of these mycotoxins are known kidney and liver toxins. Aspergillus oryzae sp. – This species is considered an occasional pathogen. Aspergillus parasiticus sp. – There is limited evidence suggestive that this mycotoxin is carcinogenic to both animals and humans, and is poisonous primarily by ingestion. Laboratory experiments indicate that it is both teratogenic and mutagenic at molecular cell levels. Its production is dependent on growth conditions and nutrient sources. Aspergillus pencilloides sp. – A species that is not considered as being any danger to animals or humans, but is found in areas with low water activity such as house dust and in various foods. As in all fungi species this type can be allergenic to some people. Aspergillus restrictus sp. – This species is considered as occasionally pathogenic to animals and humans. Aspergillus sydowi sp. – A species that is considered only occasionally pathogenic. It is associated with aspergillosis of the lungs, otomycosis (ear infection), and onchomycosis (infection of the fingers and toes). It produces the mycotoxins Patulin and Citrinin associated with animal and human diseases. Aspergillus terreus sp. – This species is normally found in warmer soil, grains, straw, cotton, and decomposing vegetation. It is known to produce the mycotoxins Patulin and Citrinin, which are associated with disease in animals and humans. This fungus is associated with aspergillosis of the lungs and or disseminated aspergillosis. It is found as an isolate from otomycosis (ear infection) and onychomycosis (infections of the fingers and/or toes). Aspergillus ustus sp. – A species considered as occasionally pathogenic to animals and humans in triggering allergenic reactions. Aspergillus versicolor sp. – This species is occasionally considered as pathogenic, and is commonly found in soil, hay, cotton, and dairy products. It produces the mycotoxins Sterigmatocystin and Cyclopiaxonic Acid. Sterigmatocystin is reported to be a carcinogen. These mycotoxins can cause diarrhea and upset stomach and are reported to be kidney and liver carcinogens (cancer-causing). Aspergillus Wentii sp. – This fungus is considered allergenic and occasionally pathogenic. It is associated with Otitis media (middle-ear inflammation/infections), burns, and infections. Aureobasidium sp. – Commonly considered as contaminants found in multiple habitats. However this fungi genus is often responsible for invasion by other fungi contaminants. Basidiobolus sp. – Etiologic agent of Entomophthoromycosis basidiobelae (cutaneous Zygomycosis) a chronic inflammatory lesion forming disease generally restricted to the limbs, chest, and back. Basidiomycetes sp.++ – Consist of fungal spores from mushrooms that are not identifiable on a culture plate, which are considered at times to be allergenic to both animals and humans. Basidiospores sp. – These are generally referred to as “mushrooms,” and are very common with many genera types. Most Basidiomycetes will not fruit on laboratory media and form sterile mycelia (seeds). Growth indoors is usually associated with “dry rot” in nutrient materials that destroy the structural integrity of wood in buildings. Many genera types are known allergens and few types are able to cause rare opportunistic infections. Beauveria sp. – These are considered contaminants, are known pathogens in some animals/insects, but rarely adversely affect humans. Bipolaris sp. – A fungus with large spores that normally present in the upper respiratory tract. This species is known to produce the mycotoxin Sterigmatocystin that can damage the kidneys and liver. Blastomyces sp. – This species is observed as a known pathogen commonly found in soil. It is a dimorphic filamentous fungus (capable of existing as a yeast or fungi under certain environmental conditions) that is known to cause blastomycosis, a chronic infection characterized by pus-forming and possibly chronic lesions in any part of the body. The ailment usually begins in the lungs and disseminates to the skin and bones. Botrytis sp.++ – This fungal species is observed as a known contaminant affecting soft fruit and decaying plant/vegetation life. It is a known allergen mainly observed in skin test reactions and can cause asthma attacks. Candida sp. – Part of the normal flora of the mouth and other mucous membranes in the body. Thrush and other diseases caused by Candida albicans usually occur after prolonged treatment with antibiotics or steroids. The environment is not a likely source of exposure for this (yeast-like and mostly opportunistic pathogenic) fungi species, and its cells are usually not observed as airborne. These species are allergenic, and in pathogenic form present as a rash, intertrigo (skin irritations on opposing surfaces), yeast infection, and thrush (dryness usually of throat/mouth). Cephalosporium sp. – (Refer to Acremonium sp.) Chaetomium sp.++ – A large ascomycetous (multi-celled) fungus producing perithecia (flask-shaped body through which ascospore [asexual spore] escape) commonly found in indoor environments. It is commonly found in a variety of substrata containing abundant cellulose, including paper and plant compost. It is observed as an allergen and in rare instances, can cause infection. Chrysosporium sp. – A species observed as contaminants that can cause animal and human disease in rare instances. Cladosporium sp. (Hormodendrum sp.) – This species is the most common species of any fungus found in indoor environments with indoor counts less than outdoor counts. It can fluctuate greatly from day-to-day, and is observed in higher numbers during the summer months and in reduced numbers during the winter months. Indoor species of Cladosporium sp. often differ from outside species. It is commonly observed on the surface of fiberglass duct lining in HVAC systems and in the interior of supply ducts. Most species are commonly considered contaminants that colonize on dead organic matter. A wide variety of plants are nutrient sources for this fungi species found in foods, paints, dead plants, soil, straw, woody plants, and textiles. It is observed to cause mycosis (fungal disease) and acute symptoms of extrinsic asthma (immediate-type hypersensitivity Type I). Acute symptoms of high-level exposure to these species include edema (fluid buildup) and bronchia spasms and, in some cases, the development of pulmonary emphysema (chronic obstructive disease of the lungs). Cladosporium fulvum sp. (Fulvia fulva) – Found on the leaves of tomatoes and can be allergenic to both animals and humans. Cladosporium herbarum sp. – Observed as contaminants and allergens. Found on paint, dead plants, soil, straw, woody plants, and textiles. Cladosporium macrocarpum sp. – Observed as contaminants and allergens. Found on paint, dead plants, soil, straw, woody plants, and textiles. Cladosporium sphaerospermum sp. – Observed as contaminants and allergens. This species is normally a secondary invader of foods, soil, paints, plants, and textiles. Coccidiodes sp. – Observed to cause Coccicioidmycosis, a disease carried on wind-blown dust particles and inhaled by animals and humans. Normally endemic in hot, dry regions, it starts with the symptoms of a mild cold influenza, then after a brief remission returns marked by a constant low-grade fever, anorexia, and possible weight loss. Other critical symptoms such as cyanosis (bluish discoloration of the skin caused by deoxygenated blood or structured defect in the hemogloblin molecule), dyspnea (distressed breathing), hemoptysis (coughing up of blood from the respiratory tract), focal skin lesions (localized skin boil, rash, sore, or wound) resembling erythema nodosum (hypersensitive reaction or redness that is sensitive to the touch), and arthritic pain in bones/joints may also present. Conidobolus sp. – Observed to cause entomophthoromycosis, a chronic inflammatory disease of the nasal mucosa. Cryptococcus sp. – A yeast-like fungi genus, normally found in pigeon feces, generally observed as non-pathogenic with the exception of medical cases involving severely immunosuppressed patients. Cryptococcus neoformans species is known to present lung and brain infections in susceptible patients. Cryptostroma corticale sp.++ – Observed as possibly allergenic to animals and humans, but non-pathogenic. Normally this species is found on the bark of maple and sycamore trees and on stored burning logs. Cunninghamella sp. – Observed to cause disseminated (dispersed or spread out, as in and organ or the entire body) and pulmonary (lungs or respiratory) infections in immune compromised persons. Cuvularia sp. – Observed as allergenic to animals and humans, this species can cause corneal (eye) infections, mycetoma (a severe fungal infection involving subcutaneous [skin] tissue, fascia [fibrous connective tissue], and bone tissue) in immune compromised persons. Dreschlera sp. – Observed to cause corneal infection of the eyes. Normally found on decaying foods, grains, and grasses. Dust/Dust Mite – Observed as inorganic or organic viable (live) microbe dusts. Any fine particulate dry matter or microbes capable of causing respiratory or asthmatic health problems in animals and humans. Epicoccum sp.++ – Observed as contaminants in dead plant materials but also found in air samples, these fungi species are known allergens. They are commonly found in grains, paper products, plants, soil, and textiles. Epidermophyton sp. – This species is observed as being able to cause infections of the skin and finger and toe nails. Fusarium sp. – Observed as a common soil fungus it is often found in humidifiers and are normally induced into the body by inhalation of contaminated particulate materials or spore. Several species of this genus are highly allergenic and known to produce potent tricothecene mycotoxins. These mycotoxins can adversely affect the circulatory, nervous systems, and cause skin problems and are observed to cause toxic aleukia (a marked reduction or complete absence of white blood cells/blood platelets) in animals and humans. Symptoms of toxic exposures include dermatitis (inflamed skin lesions), diarrhea, hemorrhagic syndrome (major internal bleeding), nausea, and vomiting in all animal types tested and in humans. This is a very dangerous fungi species with mycotoxin links in several cancer research studies (especially liver, kidney, and breast cancers). Fusarium solani sp. – Observed to produce trichothecenes mycotoxins that can cause severe illnesses in animals and humans (refer to Fusarium sp. above). Geotrichum sp. – Observed as a common contaminate of dairy products, fruits, grains, paper, textiles, soil and water. This particular fungi genus often present as part of the normal human flora (composition of bacilli, fungi, viruses and other microbes found to live and in many species, aid in the digestion and metabolic process of the human body). However, the Geotrichum candidum species are known to cause a secondary infection, Geotrichchosis (that can cause oral, bronchical, pharyngeal, and intestinal disorders most commonly in immune suppressed persons). Geotrichosis in addition to association with certain forms of tuberculosis is also known to be associated with allergic reactions similar to allergic aspergillosis, and a type of intestinal disorder characterized by abdominal pain, diarrhea, and rectal bleeding. This is a rare disease that can cause lesions of the bronchi, intestine, lung, mouth, and skin. Gliocladium sp.++ – Observed as a fungus that is structurally similar to Penicillium sp., and is reported to be allergenic. Helminthosporium sp.++ – Observed as allergenic. Histoplasma sp. – Observed as a pathogenic fungi genus, that in some sub-species are known to cause Histoplasmosis, a disease with presentation from benign pulmonary disease to chronic, progressive, and fatal infection in susceptible persons. Humicula sp.++ – Observed to grow on products with a high-cellulose content. Species of this fungi genus are also found in soil and on plant-life debris, and are potentially allergenic to both animals and humans. Hyaline Mycelia sp.++ – Observed as sterile mycelia (a mass of interwoven, branched, thread-like filaments, that makes up most fungi species) that are white or transparent. No fruiting structures are produced by the mycelia, and visual identification of these microorganisms is virtually impossible. They are associated with allergic symptoms. Microsporum sp. – This fungi genus is observed to cause ringworm to occur on the human scalp mostly, and is also contagious to other areas of the body. It generally attacks animals more than man and is usually transmitted through contact with animals. Monila sp. – This fungus is observed as allergenic to animals and humans and produces soft rot in the fruits of trees. Other species of this fungi genus produce a reddish color bread mold. This fungi species is known for causing infections of the cornea (eye). Mucor sp. – This is a Zygomycetes fungus (rapidly growing and multiplying on most media used for nutrition) that is a known allergen to human skin and bronchia tissues. It is observed to cause mucorosis (mucous buildup) in immune compromised persons. The sites of infection are usually the brain, eye and skin, lungs, nasal sinus, and may occur concurrently in multiple sites systemically. It is often found on dead plant material, fruits and fruit juices, horse manure, and also on animal hair, dairy products, meat and leather. Myxomycetes sp. – This is a common mold that have both dry and wet spore. In its initial growth phase it requires high moisture content. Myxomycetes do not grow well on general fungi nutritional sources, are not considered a true fungi species, and cannot be distinguished from smuts (soot or sooty matter). Nigrospora sp.++ – This fungi species is observed to be allergenic to animals and humans. Paecilomyces sp. – This is a fungi genus commonly found on compost, dead plants, in dust and on soil products less than in the air, and is observed to cause the decomposition of foods and be allergenic to animals and humans, but is rarely pathogenic to humans. It is found in warm climates and arid regions. Paecilomyces variotii species can cause Paecilomycosis, associated with contaminated humidifiers a known cause of pneumonia, cornea infections, and other diseases such as Wood Trimmers Disease. When found growing on arsenic substrate it may produce arsine gas. This can occur on wallpapers covered with paris green. Its mycotoxins include: paecilotoxins, byssachlamic acid, variotin, ferrirubin, viritoxin, indole-3-acetic acid, fusigen, and patulin. Papulospora sp.++ – This fungi species is considered allergenic to animals and humans and is found on decaying plants, manure, paper, soil, and textiles. Penicillium sp. – Over 200 species are categorized into this fungi genus, therefore identification to a specific species is difficult in laboratory and use of testing apparatus. Often found in aerosol samples, it is found on carpets, wallpaper, and on fiberglass duct insulation. Many species of Penicillium are common contaminants on various substrates and are known as potential mycotoxin producers. These species are known to produce the following mycotoxins: chryogine, citreoviridin, citrinin, cyclopiazonic acid, decumbin, griseofulvin, isofumigaclavine A, meleagrin, mycophenolic acid, ochratoxin, patulin, penicillic acid, penicillin, penitrem A, peptide nephrotoxin, roquefortine C & D, verrruculogen, viomellein, xanthocillin X, and xanthomegin. Phoma sp. – This fungi genus is considered as an indoor air allergen similar to the early growth stages of Chaetominum sp. It is normally isolated from soil and plant life, especially potatoes. It produces “pink spotting” on painted surfaces and can produce antigens that cross-react with those of the Alternaria sp. It is known to grow on butter, paint cement and rubber and is also associated with Phalohyphomycosis a systemic or subcutaneous disease. Pithomyces sp.++ – This fungal species grows on dead grass in pastures and are known to cause facial eczema in ruminants (cows, deer, goats, sheep, etc.). It is regarded as allergenic to humans, but not pathogenic. Rhizomucor sp. – This is a Zygomycetous fungi genus known to be allergenic. It is known to cause mucorosis in immune compromised persons. It is similar to Mucor sp. Multiple sites of infection include the brain, eyes, lungs, nasal sinus, and skin. Rhizopus sp. – This is a common saprophyte that grows on a variety of substrates, especially spoiled food. It is known to cause human allergies. It is similar to Mucor sp. Multiple sites of infection include the brain, eyes, lungs, nasal sinus, and skin. Rhodotorula sp.- This is a reddish colored yeast typically found in moist environments such as carpeting, cooling coils, and drain pans. In some countries it is the most common yeast genus identified in the indoor air. It is observed as allergenic to animals and humans and is shown to colonize in terminally ill (severely immune compromised) patients. Saccharomyces sp. – Known as Baker’s Yeast, this species is known to be allergenic to animals and humans, and can cause eye irritation and respiratory problems if inhaled. Scorpulariopsis sp. – This species are known to produce arsine gas if growing on arsenic substrate. This can occur on wallpapers covered with paris green. It has been observed growing on a wide variety of materials including house dust. It is also associated with Type III (systemic fungal) allergies. Serpula lacrymans sp. – This species is a known cause of extrinsic asthma (immediate-type hypersensitivity or Type I [respiratory]). Acute symptoms include bronchia spasms, and edema. In chronic cases pulmonary emphysema may develop. Smut – This is a common species observed as members of the Basidiomycetes. Smuts do not usually grow indoors, is often found on soot/sooty materials, requires a living plant as a host for sporulation (growth), and will not sporulate on laboratory media. Smut spores are almost indistinguishable from the Myxomycetes sp. Sporobolomyces sp.++ – This species is known as an allergen to animals and humans. Sporothrix schenckii sp. – This species is known to cause Sporotrichosis, a common chronic fungal infection. It is normally characterized by evidence of skin ulcers and subcutaneous nodules found along lymphatic channels. It rarely spreads to involve, bones, lungs, joints, or muscles. The fungus is found in soil and decaying vegetation and usually enters the skin by accidental injury. Sporotrichum sp.++ – This species is a known allergen in animals and humans. Often confused taxonomically with Sporothrix sp., this species does not cause Sporotrichohosis. Stachybotrys chartarum (atra) sp. – Several strains of 15 known variants of this genus are known to produce macrocylic trichothecene mycotoxins which include the following: cyclosporins, roidin E, stachybotryalactone, stratoxin F, G, & H, trichoverrol, and verrucarin J. All of the Stachybotrys sp. produce forms of these lethal mycotoxins known to have caused death in certain livestock animals. The Stachybotrys mycotoxins are present on the fungal spores. This is a slow growing fungus on laboratory media. It does not compete well with other rapidly growing fungi species and grows on building materials with high cellulose, low nitrogen content. It is often found in areas with relative humidity above 55 percent and subject to temperature fluctuations. People chronically exposed to the mycotoxins Stachybotrys sp. produces report cold/flu-like symptoms, dermatitis, diarrhea, fatigue, intermittent local hair loss, generalized malaise, headaches, and sore throats. These mycotoxins are known to suppress the immune system affecting lymphoid tissue and bone marrow. Animals injected with the mycotoxins from this fungus exhibit the following symptoms: necrosis and hemorrhage within the brain, thymus, spleen, intestine, lung, heart, lymph node, liver, and kidneys. Its adverse affects by absorption of the mycotoxins in the human lungs are known as Pneumomycosis. This microorganism is rarely found in outdoor air samples and is usually difficult to find in indoor air as well. Unless it is physically disturbed or (possibly a drop in relative humidity) it will not usually be detected by indoor testing often contaminating wall areas behind furniture, pictures, and wall spaces. The spores are found in a gelatinous mass. Spores of this microbe species often die soon after release into the air but still remain highly allergenic and toxigenic. Percutaneous absorption in skin exposure is known to cause mild health-related symptoms. Stemphylium sp.++ – This species is known to be allergenic to animals and humans, and is normally isolated from cellulose materials and dead plants. Syncephalastrum sp. – A fungus observed to cause respiratory infections characterized by a solid intracavitary (pertaining to space within a body cavity) fungal ball. Torula sp.++ – A fungus observed as allergenic to animals and humans. Trichoderma sp. – This fungus if commonly found in dead trees, pine needles, paper, soil and unglazed ceramics. It is observed as producing antibiotics that are toxic to humans and is a known allergen to animals and humans. This fungus is easily recognized by its fast growing, quickly spreading white, green or yellow colonies. It is one of the most widely spread soil fungi and is frequently isolated from varied geographical locations. It colonizes on dead leaves, fallen timber, compost heaps and on activated sludge. With other fungi, Trichoderma sp., are highly aggressive. The have the ability to kill other fungi with their mycotoxins and then consume them using a combination of enzymes. Because Trichoderma degrades cellulose, it is often found in water or moisture damaged buildings. The Trichoderma species produces the following mycotoxins: Tricothecene and cyclic peptides, gliotoxin, isocyanides, trichodermin, and trichotoxin A. Trichophyton sp.++ – This fungi species can cause ringworm to affect athlete’s foot, beard, skin and the scalp. It is observed as allergenic to animals and humans, and is normally found on soil and on skin. Trichothecium sp. – This fungi species is found in corn seeds, decomposing vegetation, flour and soil. The species Trichothecium roseum can produce a trichchothecene mycotoxin that is observed as associated with disease in animals and humans. It is also known allergenic. Tritirachium sp.++ – This fungi species is known to be an allergen to animals and humans. Ulocladium sp.++ – This fungi species are commonly observed as contaminants and can be very allergenic to animals and humans. It lives off decaying plant life and on the soil. Ulocladium frequently occurs in the air and dust samples and is also found on water-damaged building materials such as gypsum board. Verticillium sp. – This fungi species are commonly observed as contaminants and can be allergenic to animals and humans. On rare occasions they are known to cause infections to the eyes. They are normally found on arthropods, decaying vegetation, soil, and straw. Wallemia sp.++ – This fungus is normally found on dairy products, fruits, hay, salted meats, soil, sugary foods, and textiles, and is observed as an allergen to animals and humans. Yeasts (also) ++– Various yeasts are commonly identified on air samples. Some yeast species are observed as allergenic to animals and humans. They can cause allergies and health problems if a person has had previous long-term or high-level exposures and has developed hypersensitivity as a result. Yeasts are known to be allergenic to susceptible animals and humans when present in sufficient concentrations. NOTE: Notice that I have left the print as stated when the book was re-published in 2000. My next book certainly WILL NOT indicate that ANY mold is able to cause an allergy, because given the definition of allergens as I have posed, only the mycotoxins, endotoxins, exotoxins and other toxins along with Volatile Organic Compounds, and particulates are considered in the descriptions/definitions, and not live-celled microorganisms. By the way, I also wrote an article demonstrating that as a MYCOTOXIN (NOT A VOC, AS IS CLAIMED IN MEDICAL SCIENCE) is a known TOXIN in every sense of the word, in that in drinking it heavily, this TOXIN or POISON can cause coma or death given the amount consumed in a short period of time, or over life time of drinking. Of course if the medical field were to recognize this fact, and endorse it, far less people might die annually of " ALCOHOLISM or ALCOHOL POISONING. " However, that is utopia to a certain extent, because many health professionals like their drink, esp., wine, and sales always go up in America when things seem to be going sour with our economy! 1. Mold is linked to asthma because many scientific studies actually demonstrate clearly, both genetically and through molecular research, and through Botany and other sciences of various species for over 200 years that as " pathogens " they have the capacity and capability to in fact, do so. However, more importantly molds and mycotoxins are harder to control in products, are actually used to create products, and are more advanced to evade normal clinical observation than their counterparts... plus... " Money talks! And the economy takes priority over human life. " Don't believe this? Take a hard look at tobacco products... the FDA controls which are very limited in regulating tobacco products... sort of like the " useless as tits on a bore hog " scenario, if you get the picture. There are as many as 42 species of unhealthy molds in a cigarette. Remember what doctors used to say about smoking? 2. " In review of the scientific literature... " You know, the newest " fad " of " consensus medicine " sort of similar to that posed by the " COLLEGE " that is not " REALLY " a " REAL COLLEGE, " made up of 5,000 medical doctors and a few other " odds and ends " that make up the American " College " of Occupational and Environmental Medicine, " many of which are Qualified Medical Examiners essentially working for who? Your guess? 3. " Studies show that outdoor molds are likely... " Prove those studies exist. Indoor air is not only more contaminated than outdoor air, because it is a deliberate contained environment, but outdoor air is far more disbursed and contains much higher levels of oxygen and ultraviolet rays of the sun, natural killers of mold spores than indoors. Also, the human body functions far healthier and metabolic processes function much more balanced in outdoor air than inside. Anyone care to debate that fact with papers dedicated to scientific study over the last 2000 years? 4. Here is one of my favorites in this stupid article... " There is no credible evidence to suggest that environmental exposures to mold damages the immune system. " First, many doctors and nurses working on Intensive Care hospital wards or post surgery recovery might strongly differ. Nosocomial Infections: Nosocomial Infections Infections acquired during a hospital stay are called nosocomial infections. Formally, they are are defined as infections arising after 48 hours of hospital admission. For earlier periods it is presumably assumed that the infection arose prior to admission, though this is not always going to be true. Patients with only a brief hospital stay may find they have a nosocomial infection after leaving hospital. Nosocomial infections are common with estimates at about 10% of American hospital patients, or more than 2 million cases annually in the USA. Death rates may be 20,000 annually in the USA although some estimates are as high as 88,000 deaths. Cost estimates are as much as $4.5 billion in 1995. Hospitals generally have a high rate of nosocomial infections and the reasons are rather obvious. There are a lot of sick people around, many with depressed immune systems, and a lot of staff that deal with them every day. Nosocomial infections may arise from inhalation of droplets in the air or spread by direct hand contact from hospital staff or visitors. Most nosocomial infections afflict patients with reduced immune response either due to age, serious disease, certain medications, or recent surgery. Types of nosocomial infections: There are various types of nosocomial infections affecting various different sites. An approximate list in order of likelihood, with CDC 1996 data on frequency, is: urinary tract infections (34% in 1996), surgical site infections (17%), respiratory infections especially nosocomial pneumonia (13%), blood infections/bacteremia (14%), skin (especially burns), gastrointestinal tract infections, and central nervous system infections. Like any infectious condition, nosocomial infections can be bacterial, viral, fungal, or even parasitic. The most common pathogens include staphylococci (especially staphylococcus aureus), pseudomonas, and Escherichia coli. However, various newer pathogens are becoming more important. Fungal conditions, mainly from candida, comprise approximately 9% of nosocomial infections. Fungal nosocomial infections: Several fungi have become more common in nosocomial infections with a rate reported as 3.8 per 1,000 hospital patients (CDC/NNIS). The most common are Candida (mostly Candida albicans), Aspergillus, Fusarium, Trichosporon, and Malassezia. Candidiasis remains the most common type of nosocomial fungal infection, particularly in the immunocompromised. Risk factors for fungal infections include antibiotic treatments, chemotherapy, intravascular catheters, neutropenia, hemodialysis, or prior fungal infection. Antibiotic resistance: Many of the pathogens that cause nosocomial infections have a high level of resistance to antibiotic treatments. These emerging pathogens are the most serious concerns, because they are more difficult to treat. Some of the major concerns are methicillin resistant staphylococcus aureus (MRSA), vancomycin-resistant Staphylococcus aureus, and vancomycin-resistant enterococci (VRE). Nosocomial Urinary tract infections: Urinary tract infections are the most common nosocomial infections. These infections can be caused by various pathogens such as E. coli, Pseudomonas, or Enterococcus. Nosocomial pneumonia: Pneumonia is a common and serious nosocomial infection in the USA. Pneumonia is the second most common nosocomial infection in the United States. Most patients affected are have risk factors such as: mechanical ventilation (high risk), elderly, neonates, severe underlying disease, immunodeficiency, depressed sensorium, cardiopulmonary disease, or recent thoraco-abdominal surgery. Several types of pathogens can infect the respiratory tract and cause nosocomial pneumonia: bacterial pneumonia, Legionnaires' disease, pulmonary aspergillosis, Mycobacterium tuberculosis, and viral pneumonias such as Respiratory Syncytial Virus (RSV) and influenza. Prevention of nosocomial infections: There are numerous preventive measures ranging from the obvious to high-tech. The goals are to avoid transmission by hand, by air, and by blood. Handwashing by medical staff is the single greatest improvement, but sadly this hygiene action is often lacking in many staff. Other measures include avoiding hand contact, especially to the conjunctiva or nasal areas. Various sterilization measures are helpful ranging from simple acts like sterilizing ventilators to full scale air filtering systems in the hospital. In some cases it may be appropriate to vaccinate certain patients against particular pathogens. There are numerous measures possible to avoid transmission of nosocomial infections, and the above is a brief and incomplete discussion. (Source: http://www.wrongdiagnosis.com/mistakes/nosocomial.htm) PERSONAL NOTE: SAY DOCTOR, YOU MIGHT WANT TO VISIT A PATIENT OR TWO IN THE HOSPITAL ONCE IN AWHILE TO LEARN WHAT OTHER MORE MEDICALLY PROFICIENT MEDICAL HEALTH PROFESSIONALS SEEM TO KNOW BUT YOU DON'T! Look at what some of your REAL researchers are saying! http://cmr.asm.org/cgi/content/full/16/1/144 Then, go find a " REAL " job as a collector of garbage, because your article poses a great deal of it! R. Haney Environmental Health Projects: Research & Consulting Email: _Haney52@... ; iequality@...: snk1955@...: Fri, 30 May 2008 23:00:48 -0400Subject: [] s Hopkins U, Mold Myths, " Health Alert " aka Litigation Defense Propaganda And we wonder WHY people are not able to receive medical care for these serious illnesses. _http://www.johnshopkinshealthalerts.com/reports/lung_disorders/2012-1.html_ (http://www.johnshopkinshealthalerts.com/reports/lung_disorders/2012-1.html) Lung Disorders Special Report 9 Common Mold Myths Media reports have linked indoor mold exposure to everything from asthma to headaches. But what’s the real scientific evidence that exposure to mold in your home actually can cause physical symptoms? A recent review of scientific literature about mold-related diseases found that, while mold can cause certain health problems, many common claims just don’t hold up under scrutiny. Five allergists, including A. Wood, M.D., of the s Hopkins University School of Medicine, set out to define what can and can’t be proved about mold exposure. Here’s what they found in their review: Toxic mold. Popular reports about the health effects of mold are likely to include the term “toxic mold.” But that term can be misleading, the experts say. They point out that only certain mold spores produce toxins, and only under certain circumstances. Just because a particular mold can produce toxins doesn’t mean it will. Even if the mold is producing toxins, a person must breathe in a sufficient dose to be affected. It is highly unlikely that you could inhale enough mold in your home or office to receive a toxic dose. Mold and Asthma. While allergic responses to inhaling mold are a recognized factor in lower airway disease such as asthma, studies show that outdoor mold is more likely to cause problems for asthmatics than mold found indoors. A better assessment of the effects of indoor mold on people with asthma would require studies that follow people over a long period and take into account factors that could affect the results, such as humidity and other airborne allergens and irritants. Mold and Allergies. The link between mold and allergies is even weaker, the experts say. Current research doesn’t provide a persuasive case that exposure to mold in the outdoor air plays a role in allergies, and studies linking indoor molds to upper airway allergy are even less compelling. Mold and Skin Rashes. Exposure to molds doesn’t contribute to atopic dermatitis, or rashes. Mold and Sinusitis. There’s no clear-cut evidence that sensitivity to mold causes chronic sinusitis, nor are there conclusive data to show that mold-killing antifungal drugs such as amphotericin, applied to the nasal passages, are an effective treatment for sinusitis. Mold and Infection. Superficial fungal infections, such as toenail fungus or jock itch, generally result from fungi that develop inside the warm, moist environments found in shoes or tight garments. Thrush can develop inside the mouths of people with weakened immune systems, such as those who have AIDS or cancer. These infections generally are not the result of exposure to mold in the home or workplace. Mold and Irritation. Mold found indoors, even inside damp buildings, is not likely to cause irritation of the eyes or throat -- and if it does, the effects are short-lived. Symptoms or signs persisting weeks after exposure and those accompanied by complaints related to the nervous system, brain, or whole body (such as those attributed to chronic fatigue) can’t be pinned on the irritant effects of mold exposure. Mold and Immune System Damage. There is no credible evidence to suggest that environmental exposure to mold damages the immune system. The experts warn against immune-based tests given to look for intolerance to mold and other substances in the environment—so-called multiple chemical sensitivity. The authors specifically advise against using blood tests that look for a wide range of non-specific changes in the immune system. They also discourage using tests of autoantibodies, which are abnormal antibodies that the body sometimes produces in reaction against its own tissues. These tests are expensive and do not provide useful information that will help to diagnose or manage diseases related to mold, they say. Mold and Hypersensitivity Pneumonitis. This uncommon inflammation of the lungs, an example of which is Farmer’s Lung, is caused by exposure to an allergen, usually organic dust that may come from animal dander, molds, or plants. A person generally develops this condition only after high-dose or prolonged exposure, or both, to mold or other allergens. Much of the hoopla over mold exposure came in the wake of Hurricane Katrina, the experts note in their report, which appeared in the Journal of Allergy and Clinical Immunology. The flood-ravaged areas of the Gulf Coast, sadly, have provided a natural laboratory, which enables medical researchers to address lingering questions about the health effects of mold. Posted in _Lung Disorders_ (http://www.johnshopkinshealthalerts.com/reports/lung_disorders/) on May 22, 2008**************Get trade secrets for amazing burgers. Watch " Cooking with Tyler Florence " on AOL Food. (http://food.aol.com/tyler-florence?video=4 & ?NCID=aolfod00030000000002)[Non-text portions of this message have been removed] _________________________________________________________________ Make every e-mail and IM count. Join the i’m Initiative from Microsoft. http://im.live.com/Messenger/IM/Join/Default.aspx?source=EML_WL_ MakeCount Quote Link to comment Share on other sites More sharing options...
Guest guest Posted May 31, 2008 Report Share Posted May 31, 2008 Read this for the 3rd time, & nbsp; They are going striaght for Shoemakers research. & nbsp; They are saying that the blood work tests for this are to expensive and are not useful info for diagnosing mold related desease's. & nbsp; & nbsp; & nbsp; & nbsp; Isn't that an admission that there are mold illnesses? So what do they suggest for diagnosing these mold related desease's? From: snk1955@... & lt;snk1955@... & gt; Subject: [] s Hopkins U, Mold Myths, " Health Alert " aka Litigation Defense Propaganda , iequality Date: Friday, May 30, 2008, 7:00 PM And we wonder WHY people are not able to receive medical care for these serious illnesses. _http://www.johnshop kinshealthalerts .com/reports/ lung_disorders/ 2012-1.html_ (http://www.johnshop kinshealthalerts .com/reports/ lung_disorders/ 2012-1.html) Lung Disorders Special Report 9 Common Mold Myths Media reports have linked indoor mold exposure to everything from asthma to headaches. But what’s the real scientific evidence that exposure to mold in your home actually can cause physical symptoms? A recent review of scientific literature about mold-related diseases found that, while mold can cause certain health problems, many common claims just don’t hold up under scrutiny. Five allergists, including A. Wood, M.D., of the s Hopkins University School of Medicine, set out to define what can and can’t be proved about mold exposure. Here’s what they found in their review: Toxic mold. Popular reports about the health effects of mold are likely to include the term “toxic mold.” But that term can be misleading, the experts say. They point out that only certain mold spores produce toxins, and only under certain circumstances. Just because a particular mold can produce toxins doesn’t mean it will. Even if the mold is producing toxins, a person must breathe in a sufficient dose to be affected. It is highly unlikely that you could inhale enough mold in your home or office to receive a toxic dose. Mold and Asthma. While allergic responses to inhaling mold are a recognized factor in lower airway disease such as asthma, studies show that outdoor mold is more likely to cause problems for asthmatics than mold found indoors. A better assessment of the effects of indoor mold on people with asthma would require studies that follow people over a long period and take into account factors that could affect the results, such as humidity and other airborne allergens and irritants. Mold and Allergies. The link between mold and allergies is even weaker, the experts say. Current research doesn’t provide a persuasive case that exposure to mold in the outdoor air plays a role in allergies, and studies linking indoor molds to upper airway allergy are even less compelling. Mold and Skin Rashes. Exposure to molds doesn’t contribute to atopic dermatitis, or rashes. Mold and Sinusitis. There’s no clear-cut evidence that sensitivity to mold causes chronic sinusitis, nor are there conclusive data to show that mold-killing antifungal drugs such as amphotericin, applied to the nasal passages, are an effective treatment for sinusitis. Mold and Infection. Superficial fungal infections, such as toenail fungus or jock itch, generally result from fungi that develop inside the warm, moist environments found in shoes or tight garments. Thrush can develop inside the mouths of people with weakened immune systems, such as those who have AIDS or cancer. These infections generally are not the result of exposure to mold in the home or workplace. Mold and Irritation. Mold found indoors, even inside damp buildings, is not likely to cause irritation of the eyes or throat -- and if it does, the effects are short-lived. Symptoms or signs persisting weeks after exposure and those accompanied by complaints related to the nervous system, brain, or whole body (such as those attributed to chronic fatigue) can’t be pinned on the irritant effects of mold exposure. Mold and Immune System Damage. There is no credible evidence to suggest that environmental exposure to mold damages the immune system. The experts warn against immune-based tests given to look for intolerance to mold and other substances in the environment—so-called multiple chemical sensitivity. The authors specifically advise against using blood tests that look for a wide range of non-specific changes in the immune system. They also discourage using tests of autoantibodies, which are abnormal antibodies that the body sometimes produces in reaction against its own tissues. These tests are expensive and do not provide useful information that will help to diagnose or manage diseases related to mold, they say. Mold and Hypersensitivity Pneumonitis. This uncommon inflammation of the lungs, an example of which is Farmer’s Lung, is caused by exposure to an allergen, usually organic dust that may come from animal dander, molds, or plants. A person generally develops this condition only after high-dose or prolonged exposure, or both, to mold or other allergens. Much of the hoopla over mold exposure came in the wake of Hurricane Katrina, the experts note in their report, which appeared in the Journal of Allergy and Clinical Immunology. The flood-ravaged areas of the Gulf Coast, sadly, have provided a natural laboratory, which enables medical researchers to address lingering questions about the health effects of mold. Posted in _Lung Disorders_ (http://www.johnshop kinshealthalerts .com/reports/ lung_disorders/) on May 22, 2008 ************ **Get trade secrets for amazing burgers. Watch " Cooking with Tyler Florence " on AOL Food. (http://food. aol.com/tyler- florence? video=4 & amp;? NCID=aolfod00030 000000002) Quote Link to comment Share on other sites More sharing options...
Guest guest Posted June 1, 2008 Report Share Posted June 1, 2008 I took this a different way. the first few lines they make the comments about toxic mold and basicly exclude it from there further comments about " MOLD " and I agree with them that molds not produceing mycotoxins are hatmless. I also agree that you have to be exposed to a pretty high amount of toxic mold to cause major damage (in a short period of time)(but even in low dose exposures to toxic molds,those toxins still can cause damage to weeked organs and cause effects specific to the type). what I dont agree to is the statement that even molds that are known to produce toxins dont aways do so. WRONG! WEITHER THEY PRODUCE THEM CONSTANTLY OR NOT, THE TOXINS ACCULATE IN THE INDOOR AREAS, THEY DONT PACK UP AND LEAVE, AND THEY ARE IN THE SPORES AND ATTACH TO THE SPORES SO THERES NO WAY YOU WONT BE GETTING EXPOSURE TO THE TOXINS THAT " TOXIC MOLD PRODUCES. (http://www.johnshop kinshealthalerts .com/reports/ lung_disorders/ 2012-1.html) > > Lung Disorders Special Report > > > > 9 Common Mold Myths > > > > Media reports have linked indoor mold exposure to everything from asthma to > > headaches. But what's the real scientific evidence that exposure to mold in > > your home actually can cause physical symptoms? A recent review of scientific > > literature about mold-related diseases found that, while mold can cause > > certain health problems, many common claims just don't hold up under scrutiny. > > Five allergists, including A. Wood, M.D., of the s Hopkins > > University School of Medicine, set out to define what can and can't be proved about > > mold exposure. Here's what they found in their review: > > Toxic mold. Popular reports about the health effects of mold are likely to > > include the term " toxic mold. " But that term can be misleading, the experts > > say. They point out that only certain mold spores produce toxins, and only > > under certain circumstances. Just because a particular mold can produce toxins > > doesn't mean it will. Even if the mold is producing toxins, a person must > > breathe in a sufficient dose to be affected. It is highly unlikely that you > > could inhale enough mold in your home or office to receive a toxic dose. > > Mold and Asthma. While allergic responses to inhaling mold are a recognized > > factor in lower airway disease such as asthma, studies show that outdoor mold > > is more likely to cause problems for asthmatics than mold found indoors. A > > better assessment of the effects of indoor mold on people with asthma would > > require studies that follow people over a long period and take into account > > factors that could affect the results, such as humidity and other airborne > > allergens and irritants. > > Mold and Allergies. The link between mold and allergies is even weaker, the > > experts say. Current research doesn't provide a persuasive case that exposure > > to mold in the outdoor air plays a role in allergies, and studies linking > > indoor molds to upper airway allergy are even less compelling. > > Mold and Skin Rashes. Exposure to molds doesn't contribute to atopic > > dermatitis, or rashes. > > Mold and Sinusitis. There's no clear-cut evidence that sensitivity to mold > > causes chronic sinusitis, nor are there conclusive data to show that > > mold-killing antifungal drugs such as amphotericin, applied to the nasal passages, are > > an effective treatment for sinusitis. > > Mold and Infection. Superficial fungal infections, such as toenail fungus or > > jock itch, generally result from fungi that develop inside the warm, moist > > environments found in shoes or tight garments. Thrush can develop inside the > > mouths of people with weakened immune systems, such as those who have AIDS or > > cancer. These infections generally are not the result of exposure to mold in > > the home or workplace. > > Mold and Irritation. Mold found indoors, even inside damp buildings, is not > > likely to cause irritation of the eyes or throat -- and if it does, the > > effects are short-lived. Symptoms or signs persisting weeks after exposure and > > those accompanied by complaints related to the nervous system, brain, or whole > > body (such as those attributed to chronic fatigue) can't be pinned on the > > irritant effects of mold exposure. > > Mold and Immune System Damage. There is no credible evidence to suggest that > > environmental exposure to mold damages the immune system. The experts warn > > against immune-based tests given to look for intolerance to mold and other > > substances in the environment—so-called multiple chemical sensitivity. The > > authors specifically advise against using blood tests that look for a wide range > > of non-specific changes in the immune system. They also discourage using > > tests of autoantibodies, which are abnormal antibodies that the body sometimes > > produces in reaction against its own tissues. These tests are expensive and do > > not provide useful information that will help to diagnose or manage diseases > > related to mold, they say. > > Mold and Hypersensitivity Pneumonitis. This uncommon inflammation of the > > lungs, an example of which is Farmer's Lung, is caused by exposure to an > > allergen, usually organic dust that may come from animal dander, molds, or plants. A > > person generally develops this condition only after high-dose or prolonged > > exposure, or both, to mold or other allergens. > > Much of the hoopla over mold exposure came in the wake of Hurricane Katrina, > > the experts note in their report, which appeared in the Journal of Allergy > > and Clinical Immunology. The flood-ravaged areas of the Gulf Coast, sadly, > > have provided a natural laboratory, which enables medical researchers to address > > lingering questions about the health effects of mold. > > > > Posted in _Lung Disorders_ > > (http://www.johnshop kinshealthalerts .com/reports/ lung_disorders/) on May 22, 2008 > > > > ************ **Get trade secrets for amazing burgers. Watch " Cooking with > > Tyler Florence " on AOL Food. > > (http://food. aol.com/tyler- florence? video=4 & amp;? NCID=aolfod00030 000000002) > > > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted June 1, 2008 Report Share Posted June 1, 2008 hope this is the right link on fungal lung infection/damage. if you read this it so obviously shows that just like anywhere else in the environment, molds that produce toxins do so to condiction the area for the servival of the mold itself. looks to me that it does the same thing in our bodies. so really, it seem obvious that mold without the toxins it produces would be pretty harmless. http://www.biomedcentral.com/1471-2180/7/5 > > I took this a different way. the first few lines they make the > comments about toxic mold and basicly exclude it from there further > comments about " MOLD " and I agree with them that molds not produceing > mycotoxins are hatmless. I also agree that you have to be exposed to > a pretty high amount of toxic mold to cause major damage (in a short > period of time)(but even in low dose exposures to toxic molds,those > toxins still can cause damage to weeked organs and cause effects > specific to the type). what I dont agree to is the statement that > even molds that are known to produce toxins dont aways do so. WRONG! > WEITHER THEY PRODUCE THEM CONSTANTLY OR NOT, THE TOXINS ACCULATE IN > THE INDOOR AREAS, THEY DONT PACK UP AND LEAVE, AND THEY ARE IN THE > SPORES AND ATTACH TO THE SPORES SO THERES NO WAY YOU WONT BE GETTING > EXPOSURE TO THE TOXINS THAT " TOXIC MOLD PRODUCES. > > (http://www.johnshop kinshealthalerts .com/reports/ lung_disorders/ > 2012-1.html) > > > > Lung Disorders Special Report > > > > > > > > 9 Common Mold Myths > > > > > > > > Media reports have linked indoor mold exposure to everything from > asthma to > > > > headaches. But what's the real scientific evidence that exposure > to mold in > > > > your home actually can cause physical symptoms? A recent review of > scientific > > > > literature about mold-related diseases found that, while mold can > cause > > > > certain health problems, many common claims just don't hold up > under scrutiny. > > > > Five allergists, including A. Wood, M.D., of the s > Hopkins > > > > University School of Medicine, set out to define what can and > can't be proved about > > > > mold exposure. Here's what they found in their review: > > > > Toxic mold. Popular reports about the health effects of mold are > likely to > > > > include the term " toxic mold. " But that term can be misleading, > the experts > > > > say. They point out that only certain mold spores produce toxins, > and only > > > > under certain circumstances. Just because a particular mold can > produce toxins > > > > doesn't mean it will. Even if the mold is producing toxins, a > person must > > > > breathe in a sufficient dose to be affected. It is highly unlikely > that you > > > > could inhale enough mold in your home or office to receive a toxic > dose. > > > > Mold and Asthma. While allergic responses to inhaling mold are a > recognized > > > > factor in lower airway disease such as asthma, studies show that > outdoor mold > > > > is more likely to cause problems for asthmatics than mold found > indoors. A > > > > better assessment of the effects of indoor mold on people with > asthma would > > > > require studies that follow people over a long period and take > into account > > > > factors that could affect the results, such as humidity and other > airborne > > > > allergens and irritants. > > > > Mold and Allergies. The link between mold and allergies is even > weaker, the > > > > experts say. Current research doesn't provide a persuasive case > that exposure > > > > to mold in the outdoor air plays a role in allergies, and studies > linking > > > > indoor molds to upper airway allergy are even less compelling. > > > > Mold and Skin Rashes. Exposure to molds doesn't contribute to > atopic > > > > dermatitis, or rashes. > > > > Mold and Sinusitis. There's no clear-cut evidence that sensitivity > to mold > > > > causes chronic sinusitis, nor are there conclusive data to show > that > > > > mold-killing antifungal drugs such as amphotericin, applied to the > nasal passages, are > > > > an effective treatment for sinusitis. > > > > Mold and Infection. Superficial fungal infections, such as toenail > fungus or > > > > jock itch, generally result from fungi that develop inside the > warm, moist > > > > environments found in shoes or tight garments. Thrush can develop > inside the > > > > mouths of people with weakened immune systems, such as those who > have AIDS or > > > > cancer. These infections generally are not the result of exposure > to mold in > > > > the home or workplace. > > > > Mold and Irritation. Mold found indoors, even inside damp > buildings, is not > > > > likely to cause irritation of the eyes or throat -- and if it > does, the > > > > effects are short-lived. Symptoms or signs persisting weeks after > exposure and > > > > those accompanied by complaints related to the nervous system, > brain, or whole > > > > body (such as those attributed to chronic fatigue) can't be pinned > on the > > > > irritant effects of mold exposure. > > > > Mold and Immune System Damage. There is no credible evidence to > suggest that > > > > environmental exposure to mold damages the immune system. The > experts warn > > > > against immune-based tests given to look for intolerance to mold > and other > > > > substances in the environment—so-called multiple chemical > sensitivity. The > > > > authors specifically advise against using blood tests that look > for a wide range > > > > of non-specific changes in the immune system. They also discourage > using > > > > tests of autoantibodies, which are abnormal antibodies that the > body sometimes > > > > produces in reaction against its own tissues. These tests are > expensive and do > > > > not provide useful information that will help to diagnose or > manage diseases > > > > related to mold, they say. > > > > Mold and Hypersensitivity Pneumonitis. This uncommon inflammation > of the > > > > lungs, an example of which is Farmer's Lung, is caused by exposure > to an > > > > allergen, usually organic dust that may come from animal dander, > molds, or plants. A > > > > person generally develops this condition only after high-dose or > prolonged > > > > exposure, or both, to mold or other allergens. > > > > Much of the hoopla over mold exposure came in the wake of > Hurricane Katrina, > > > > the experts note in their report, which appeared in the Journal of > Allergy > > > > and Clinical Immunology. The flood-ravaged areas of the Gulf > Coast, sadly, > > > > have provided a natural laboratory, which enables medical > researchers to address > > > > lingering questions about the health effects of mold. > > > > > > > > Posted in _Lung Disorders_ > > > > (http://www.johnshop kinshealthalerts .com/reports/ > lung_disorders/) on May 22, 2008 > > > > > > > > ************ **Get trade secrets for amazing burgers. > Watch " Cooking with > > > > Tyler Florence " on AOL Food. > > > > (http://food. aol.com/tyler- florence? video=4 & amp;? > NCID=aolfod00030 000000002) > > > > > > > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted June 1, 2008 Report Share Posted June 1, 2008 Snk, Would you be able to post the whole article or send it to me, please. The link said that the article was no longer avalable. Many thanks, Sam > In all seriousness I think we need a study concerning the > health Quote Link to comment Share on other sites More sharing options...
Guest guest Posted June 1, 2008 Report Share Posted June 1, 2008 seriously, here's 5 allergest's saying that " non-toxic produceing molds " dont caude any illnesses and probably not even allergies or asthma. YEP, MORE PROOF THAT IT'S THE BIOTOXINS THAT CAUSE OUR DISEASES. I think they are right.non-toxic molds do no harm. my thoughts from how I veiw their comments : 9 Common Mold Myths Media reports have linked indoor mold exposure to everything from asthma to headaches. But what's the real scientific evidence that exposure to mold in your home actually can cause physical symptoms? A recent review of scientific literature about mold-related diseases found that, while mold can cause certain health problems, many common claims just don't hold up under scrutiny. Five allergists, including A. Wood, M.D., of the s Hopkins University School of Medicine, set out to define what can and can't be proved about mold exposure. Here's what they found in their review: Toxic mold. Popular reports about the health effects of mold are likely to include the term " toxic mold. " But that term can be misleading, the experts say. They point out that only certain mold spores produce toxins, and only under certain circumstances. Just because a particular mold can produce toxins doesn't mean it will. Even if the mold is producing toxins, a person must breathe in a sufficient dose to be affected. It is highly unlikely that you could inhale enough mold in your home or office to receive a toxic dose. (well thank god it's a rare that people get exposed to this level because,yes, it can mess you up. if it wasn't rare the world would be in deep s##t. scary thought of even 50% pf people walking around with TBI and PTSD. yikes!!!!) Mold and Asthma. While allergic responses to inhaling mold are a recognized factor in lower airway disease such as asthma, (clairify " allergic response " do you mean a hypersensity reaction? clairify hypersensitiviy. ) studies show that outdoor mold is more likely to cause problems for asthmatics than mold found indoors. (yes, enless there's a toxic mold problem indoors) A better assessment of the effects of indoor mold on people with asthma would require studies that follow people over a long period and take into account factors that could affect the results, such as humidity and other airborne allergens and irritants. (please, thars nitpicking. everything involved,dust,roached,mites,carpet,ect. all have mold and mold toxins involved. you cant seperate it.) Mold and Allergies. The link between mold and allergies is even weaker, the experts say. Current research doesn't provide a persuasive case that exposure to mold in the outdoor air plays a role in allergies, (WHT'S THE DIFFERENCE BERWEEN INDOOR AND OUTDOOR? yes, why are you even talking about allergies in a non-toxic form?) and studies linking indoor molds to upper airway allergy are even less compelling. (yes, because it's not a " allergy " it's a toxic reaction/damage from toxin exposure) Mold and Skin Rashes. Exposure to molds doesn't contribute to atopic dermatitis, or rashes. (no, but those mold toxins can sure work up a itch,burn, and roxin exposure causes vasculitis which causes tiny red dots that may be what people think is a rash) Mold and Sinusitis. There's no clear-cut evidence that sensitivity to mold causes chronic sinusitis, (no, because it's the toxins that first distroy your sinuses/mucus system/tissue that than cause many irritants to aggervate that condiction) nor are there conclusive data to show that mold-killing antifungal drugs such as amphotericin, applied to the nasal passages, are an effective treatment for sinusitis. (no, could even be very dangerous if you have severe nasal/olfacty damage that goes into the brain. antifungal's aren't toxin free. may help some people, but as ling as your breathing your taking in more irritants, besicly your kindof screwed with severe damage that doesn't heal) Mold and Infection. Superficial fungal infections, such as toenail fungus or jock itch, generally result from fungi that develop inside the warm, moist environments found in shoes or tight garments. (duh, warm and moist, a toxic molds dream come true) Thrush can develop inside the mouths of people with weakened immune systems, such as those who have AIDS or cancer. (toxins SUPPRESS the aquired immune system,because the innate immune system is what triggers the aquired immune system to take actionm and when the innate immune system sends out our killer cells to attack the foriegn intruders and our killer cells get killed off, the signal for the aquired immune system diesn't happen. so add suppressed immune system to that please.) These infections generally are not the result of exposure to mold in the home or workplace. (bet me and lose, do some reading on mycosis) Mold and Irritation. Mold found indoors, even inside damp buildings, is not likely to cause irritation of the eyes or throat (unless theres toxins produced by molds!!, gee, wheres all those studies where theres a mold problem in the home but the molds found were not know to be the toxic mold types?) -- and if it does, the effects are short-lived. (short lived only if you get out and stay out and only if it's a low dose exposure that doesn't distory your mucus lineing and cause toxic overload,break down BBB's and go to the brain.) Symptoms or signs persisting weeks after exposure and those accompanied by complaints related to the nervous system, brain, or whole body (such as those attributed to chronic fatigue) can't be pinned on the irritant effects of mold exposure. (gee, I seem to have gathered during research that allergens,irritants and toxins weren't the sale thing. maybe you should be more specific about what your refering too, oh, wait, in the allergest world they are all lumped together and only seperated when the need arises to play the word game.maybe because they are a result of biotoxin exposure and the irritants only become irritants after the toxins have caused the organ damage)(please refer to irritants as toxic or non-toxic)(please refer to allergens as toxic or non-toxic) Mold and Immune System Damage. There is no credible evidence to suggest that environmental exposure to mold damages the immune system. (but theres all kinds of proof of what mold toxins can do) (the innate immune system is the first defence against foriegn invaders, it disturbs me that " expert " allergest's dont have expertize of immunology.) The experts warn against immune-based tests given to look for intolerance to mold and other substances in the environment—so-called multiple chemical sensitivity. The authors specifically advise against using blood tests that look for a wide range of non-specific changes in the immune system. They also discourage using tests of autoantibodies, which are abnormal antibodies that the body sometimes produces in reaction against its own tissues. (THAT'S PRETTY STUPIED, LET'S SEE, OUR ON CELLS CAN BE MORE TOXIC THAN FORIEGN TOXIC INVADERS? HUMM, NOT WHAT I'VE READ.) These tests are expensive and do not provide useful information that will help to diagnose or manage diseases related to mold, they say. (WHAT'S THAT? DISEASES RELATED TO MOLD? DONT YOU MEAN DISEASES RELATED TO THE BIOTOXINS THAT TOXIC MOLDS PRODUCE?)(WELL, THESE TESTS DO PROVE EXPOSURE TO THE MOLD TYPES AND IF THOSE TYPES ARE KNOWN BIOTOXIN PRODUCERS,WAALAA, YOU HAVE PROOF TO YOUR EXPOSURE TO THE MOLD TOXINS BECAUSE, AS YOU SAID, NON0TOXIC PRODUCEING MOLDS ARE HARMLESS) Mold and Hypersensitivity Pneumonitis. This uncommon inflammation of the lungs, an example of which is Farmer's Lung, is caused by exposure to an allergen, usually organic dust that may come from animal dander, molds, or plants. A person generally develops this condition only after high-dose or prolonged exposure, or both, to mold or other allergens. (organic dust, dont you mean toxic organic dust?) (YES, WE KNOW, EVERYTHING IS REFERED TO AS A ALLERGEN, EVEN BIOTOXINS) Much of the hoopla over mold exposure came in the wake of Hurricane Katrina, (sad that it's takes something like that to get attm. I'd like some proper medical attn. but I'm not katrina) the experts note in their report, which appeared in the Journal of Allergy and Clinical Immunology. The flood-ravaged areas of the Gulf Coast, sadly, have provided a natural laboratory, which enables medical researchers to address lingering questions about the health effects of mold. (WELL WHY DONT YOU GET BUSY ADDRESSING THEM THAN?) Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.